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Abstract 
 
Bacterial resistance to antibiotics has focused primarily on the role of 
acquired genetic elements contained in transposons and plasmids. In contrast to 
this view, many bacterial species are equipped with intrinsic mechanisms to 
survive exposure to a wide variety of antimicrobial compounds. This form of 
resistance is mediated through regulated expression of efflux pump systems, 
reducing enzymes, and enzymes in cellular metabolism. Modulating this 
response in Escherichia coli are three homologous, transcription factors: MarA, 
SoxS, and Rob. Together, these transcription factors serve as master regulators 
of the extensive mar/sox/rob regulon that has been directly implicated in 
multidrug resistance found in clinical and laboratory isolates. In this work, we 
examine the degree of genetic cross-talk between these regulatory systems and 
the cooperative role of these three transcriptional regulators in activating 
downstream targets. 
 
The overarching goal of this work is to provide an integrated model for the 
mar/sox/rob regulatory network. First, the role of MarA, SoxS, and Rob in cross-
regulating and auto-regulating expression from the marRAB, soxRS, and rob loci 
is explored. Previous evidence has suggested the potential for a fully 
interconnected transcriptional regulatory network between marRAB, soxRS, and 
rob. Using a genetic approach, the transcription-level interaction between the 
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marRAB, soxRS, and rob systems was dissected and a more complete model is 
proposed. As a corollary, evidence is presented to support a model where MarA 
serves a conditional auto-repressor of its own expression. Similarly, genetic and 
biochemical evidence is presented showing the global nutritional regulator, cyclic 
AMP receptor protein (CRP) interacts directly with the marRAB promoter region. 
Second, the role of MarA and Rob in coordinately regulating the reduction of 
OmpF expression during drug exposure is examined. The canonical model for 
this event argues that up-regulated expression of MicF (a small RNA regulator of 
OmpF translation), mediated by MarA, SoxS, and Rob, is the causal agent of 
OmpF reduction. Evidence is here provided that MarA and Rob function as 
independent pathways for micF promoter activation. Likewise, data is presented 
to suggest the possibility of a MicF-independent pathway for OmpF reduction that 
is regulated by MarA. Additionally, the reduction in OmpF expression in tolC 
mutants is found to be the result of Rob-dependent activation of MicF. Finally, 
genetic and biochemical data is presented that demonstrates the role of aromatic 
metabolites in activating the mar/sox/rob regulon through direct interaction with 
the repressor protein, MarR. Collectively, these results provide continuing steps 
towards an integrated view of the mar/sox/rob regulon and cellular physiology. 
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Chapter 1: An introduction to the mar/sox/rob regulon 
 
1.1 General perspectives on antibiotic resistance 
Bacterial resistance to antibiotics has been a persistent problem in clinical and 
public health situations for decades. Since the implementation of penicillin in the 
1940‟s to treat streptococcal septicemia (Florey, 1941), countless resistant 
strains of both commensal and pathogenic bacteria have emerged for nearly all 
antibiotics currently used in medical practice (Levy and Marshall, 2004, 
Livermore, 2009, Livermore, 2004). As treatment regiments become increasing 
limited, the need to comprehend the mechanisms of resistance and possible 
alternative treatment strategies has become paramount.  
 Bacterial resistance to antibiotics has been observed to occur through two 
primary modes; acquired resistance and intrinsic resistance (Alekshun and Levy, 
2007, Nikaido, 2009). Acquired resistance is the result of beneficial chromosomal 
mutations or more commonly the acquisition of genes encoding antibiotic 
resistance determinants. These determinants are typically encoded on mobile 
genetic elements such as plasmids, bacteriophage and transposons (Levy and 
Marshall, 2004, Alekshun and Levy, 2007, Nikaido, 2009). Intrinsic resistance, on 
the other hand, is a process where bacteria can initiate changes in cellular 
metabolism and physiology to survive exposure to antimicrobial compounds 
(Alekshun and Levy, 2007, Nikaido, 2009). The result is often no single genetic 
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determinant can account for resistance to certain classes of antibiotics. A 
defining feature of intrinsic resistance is that the genes required for this 
phenotype are naturally occurring in the host‟s genome.   
 Due to the complexity of intrinsic resistance, only a limited number of 
associated mechanisms have been extensively studied. Active mechanisms such 
as drug resistance efflux pumps being the most fully understood (Paulsen, 2003). 
Recently, efforts have been made to shed light on other physiological changes 
occurring within cells during adaption to multi-drug environments (Kohanski et al., 
2010, Kohanski et al., 2007, Kohanski et al., 2008, Bollenbach et al., 2009, Liu et 
al., 2010, Tamae et al., 2008). Combining classical microbiology with systems-
level measurements has allowed an ever more complete picture the changes 
occurring inside bacterial cells during drug exposure. 
 Though researchers have on one hand observed many of the 
physiological changes that can occur on antibiotic exposure, mapping these 
changes to changes in gene regulation has remained an uncompleted task 
(Dwyer et al., 2008, MacLean et al., 2010). The overarching goal of this work is 
to form a more complete picture of how these changes may be regulated at the 
genetic level. In the case of Escherichia coli, three independent genetic 
regulatory systems have been implicated in causing natural, low-level resistance 
to a broad spectrum of antibiotics. These systems are the marRAB, soxRS, and 
rob regulatory networks. Encoded in these systems are genes for three, 
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homologous transcriptional regulators MarA, SoxS and Rob. Each system is 
activated in response to different chemical stimuli, yet these three transcription 
factors regulate a vast, overlapping network of genes required to survive in toxic 
environments. A documented, but poorly understood, feature of these networks 
is their capacity to regulate the expression of one another. This work aims to 
explore this genetic interconnectivity and use this as a basis to understand how 
the network manages a large downstream regulon. Further, this dissertation 
attempts to expand our understanding of the possible role of intermediary 
metabolism in activating the marRAB genetic circuit. Collectively, this work 
attempts to define a clear genetic regulatory picture of the intrinsic multi-antibiotic 
resistance system of E. coli. 
 
1.2 The two general mechanisms of antibiotic resistance 
Acquired antibiotic resistance. Acquired antibiotic resistance is the result of 
beneficial mutations to genes encoding targets of antibiotic action or more 
commonly bacterial cells receiving heterologous DNA containing genes encoding 
resistance determinants from the environment (Alekshun and Levy, 2007, Levy 
and Marshall, 2004). These resistance determinants, or genes, are typically 
located in mobile genetic elements such as plasmids and transposons which can 
be introduced to bacterial cells by bacteriophage infection, conjugal transfer from 
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neighboring bacteria, or natural uptake of DNA from the environment (Alekshun 
and Levy, 2007, Levy and Marshall, 2004).  
Acquired resistance mechanisms can be generally considered as heritable 
forms of resistance (Figure 1.1). As opposed to their inducible, or intrinsic, 
counterparts, a fundamental component of the acquired resistance mechanism is 
that permanent changes are made to the host DNA, resulting in the production of 
equally resistant progeny. Partly because of these permanent genetic changes, 
acquired resistance mechanisms have readily traceable sources and have 
remained the most fully understood. 
 The first strides towards understanding the mechanisms of acquired 
resistance were made in Japan during the late 1950‟s. During this time, an 
increase in cases of septic dysentery that were not treatable with sulfonamide 
antibiotics had been observed. To determine the cause of emerging antibiotic 
resistant strains of Shigella, researchers examined numerous isolates and 
discovered that the resistance determinants were disseminated through conjugal 
transfer of plasmids (Watanabe, 1963). From this point on, other mobile elements 
such as transposons and integrons have been found in numerous bacterial 
species both in clinical settings and the environment (Alekshun and Levy, 2007, 
Levy and Marshall, 2004, Mazel, 2006). The rapid transfer of these genes 
throughout diverse bacterial species, and the capacity of these elements to 
incorporate ever-increasing numbers of antibiotic resistance genes, has resulted 
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in large-scale efforts to discover novel treatment strategies (Alekshun, 2005, 
Alekshun and Levy, 2007, Levy and Marshall, 2004). Although these problems 
have significant clinical merit, they are beyond the scope of this work and will not 
be covered further. 
  
Intrinsic antibiotic resistance. Intrinsic antibiotic resistance is a mechanism 
fundamentally different from acquired resistance. The primary source of 
divergence between these mechanisms is that intrinsic resistance is non-
heritable and typically inducible. By non-heritable resistance, it is meant that the 
resulting progeny of drug-exposed bacterial cells are genetically identical and 
equally as sensitive to antimicrobials as the unexposed parents. Likewise, the 
term inducible is meant to imply that level of resistance to particular antimicrobial 
compounds is strongly dependent on the chemical environment of cell. For 
example, and relevant to this study, the presence of salicylates in bacterial 
growth medium is known to induce resistance to a wide variety of drugs. The 
progeny of these salicylate exposed cells, however, remain sensitive to the same 
drugs in the absence of salicylates.  
An important outcome of the difference between the acquired and intrinsic 
mechanisms is pin-pointing specific determinants of intrinsic resistance is 
difficult. The primary reason for this is that intrinsic resistance typically results 
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from the concerted action of numerous cellular systems. Acquired resistance, on 
the other hand, is often due to singular, inherited factors. 
 Two prototypical examples will be covered here to illustrate the nature of 
intrinsic resistance; formation of persister populations and regulated multidrug 
resistance. Early studies on the use of antibiotics in clinical practice found 
subgroups of bacterial cells in infected patients that survived antibiotic exposure, 
yet remained sensitive to drug treatment – known as persister populations 
(Bigger, 1944). Given recent advances in genomic and systems-level 
methodologies, the elucidation of a genetic basis for persister cell development 
has advanced significantly. Based on current findings, it is clear that a number of 
host factors are at play in producing the formation of persister cells in bacterial 
populations including metabolic enzymes and chromosomally encoded toxin-
antitoxin systems (Lewis, 2008, Lewis, 2010). For example, Spoering and 
colleagues have demonstrated that enzymes involved in central metabolism such 
as glycerol-3-phosphate dehydrogenase (GlpD) are involved in the formation of 
persister cells (Spoering et al., 2006). Presumably, intermediates in central 
metabolism may serve as signals for this developmental change. Likewise, the 
recent work of Dorr and coworkers has demonstrated the role of a toxin-antitoxin 
system encoded in the E. coli chromosome as a determinant of ciproflaxin-
induced persister cell formation (Dorr et al., 2010). In both cases, it is believed 
that fluctuations in the expression of these genes is responsible for the formation 
of dormant subpopulations of bacterial cells. Despite the discovery of specific 
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mechanisms, large-scale understanding of persister development remains 
unclear (Lewis, 2010). 
 A second example, and the focus of the remaining discussion, is regulated 
multidrug resistance. Regulated resistance mechanisms are ubiquitous in 
bacterial species (Alekshun and Levy, 2007, Nikaido, 2009, Paulsen, 2003). The 
fundamental basis for regulated resistance is that cells sense the presence of an 
intracellular or extracellular concentration of toxic chemical(s) and initiate 
changes in gene expression to alter aspects of cellular physiology and 
metabolism to combat the action of the toxin(s). For E. coli, and closely related 
bacterial species, this is mediated primary through the sensory action of 
transcriptional regulators and two-component regulatory systems, that in turn 
alter the gene expression of membrane bound efflux pumps and porins, as well 
as numerous metabolic and detoxifying enzymes (Nikaido, 2009, Miller and 
Sulavik, 1996, Hirakawa et al., 2003, Baranova and Nikaido, 2002, Nagakubo et 
al., 2002, Eguchi et al., 2003, Alekshun and Levy, 2007, Viveiros et al., 2007, 
Alekshun and Levy, 1999b). A result of these changes is that cells can be 
exposed to ever increasing concentrations of toxins such as antibiotics yet 
remain viable. The most extensively studied set of intrinsic resistance regulatory 
systems are the marRAB, soxRS, and rob systems of E. coli (Demple, 1996, 
Alekshun and Levy, 1999b, Randall and Woodward, 2002). Additionally, cryptic 
regulators, such as YdeO, have been repeatedly implicated in global screens for 
antibiotic resistance (Nishino et al., 2009, Masuda and Church, 2003, Masuda 
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and Church, 2002). Additionally, a recent global expression screen has shown 
that a number of two-component regulatory systems such as EvgS/EvgA, 
CpxA/CpxR and EnvZ/OmpR are involved in conferring multiple antibiotic 
resistance through activating a number of drug efflux pump systems (Hirakawa et 
al., 2003). 
 Persister cell formation and regulated multidrug resistance exemplify the 
primary characteristic of intrinsic resistance. In each case, a phenotype is 
induced by changes in gene expression. These changes are ultimately reversible 
as they do not result in permanent modification of the host‟s DNA, allowing the 
bacterial cells to remain sensitive to re-exposure to toxins and antimicrobials. 
 
1.3 Observed mechanisms of intrinsic resistance in Escherichia coli 
Multidrug efflux pumps.  
The one universal mechanisms of intrinsic resistance in bacteria is the 
expression of multidrug efflux pumps (Poole, 2005, Nikaido, 2009, Paulsen, 
2003, Piddock, 2006). Nearly all known bacterial species encode multidrug efflux 
pumps and their widespread abundance has allowed for their systematic 
classification (Paulsen, 2003). Although the role of efflux pumps in antibiotic-
resistant clinical infection is clear, based on their observed expression in drug 
resistant isolates, the role they play in general bacterial physiology remains 
uncertain (Piddock, 2006). 
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 Genomic and structural analysis has allowed for the classification of five 
families of bacterial efflux pumps. A large number of efflux systems are members 
of the ATP-binding cassette (ABC) family and utilize adenosine triphosphate 
(ATP) as an energy source to drive transport of chemicals across the membrane. 
Numerous pumps are members of the major facilitator superfamily (MFS) that 
are typically proton/chemical anti-porters that utilize chemiosmotic energy. The 
remaining families of resistance nodulation (RND), small multidrug resistance 
(SMR), and multidrug and toxic compounds effux (MATE) families are proton and 
ion-driven efflux systems.  
 In the context of this work, the AcrAB-TolC and EmrAB-TolC efflux 
systems of E. coli will be discussed. AcrAB-TolC and EmrAB-TolC are members 
of the RND and MFS families, respectively. Each pump system is TolC-
dependent, in that they required the outer membrane pore, TolC, to transport 
chemical species across outer membrane of E. coli cells (Touze et al., 2004, 
Tanabe et al., 2009, Fralick, 1996). Both pumps are comprised of two subunits. 
AcrB and EmrB are inner membrane bound efflux pumps that contact TolC, 
whereas AcrA and EmrA are structural proteins for ancoring to the complex to 
the inner membrane (Touze et al., 2004, Husain et al., 2004). Although 
functionally similar, they differ in classification based on the homology of the 
inner-membrane pumps AcrB and EmrB to differing families of transporters. 
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 Of the two systems, AcrAB-TolC has been the most extensively linked to 
multidrug resistance in E. coli and close relatives (Touze et al., 2004, Husain et 
al., 2004, Symmons et al., 2009). This is due in part to the wide substrate range 
of the AcrAB-TolC pump for such disparate compounds as solvents, dyes and 
detergents as well as numerous lipophilic antibiotics (Ma et al., 1995, Ma et al., 
1996). Additionally, the expression of the acrAB operon, as well as the tolC gene, 
is regulated by numerous systems including marRAB, soxRS, and rob (Zhang et 
al., 2008, White et al., 1997). The net result is that AcrAB-TolC is capable to 
being expressed under numerous stressful chemical conditions and possesses 
the capacity to expel a wide range of toxins from the intracellular environment. 
This allows for E. coli to remain viable in many multidrug environments. 
 
Alteration of outermembrane porin composition. The outer membrane of 
Gram-negative bacteria is abundantly studded with molecular pores known as 
porins. These porins allow for the passive diffusion of molecules from the 
extracellular environment into the host periplasm. In E. coli, two of these major 
porins OmpC and OmpF have been implicated in the intrinsic resistance 
phenotype (Cohen et al., 1988, Pages et al., 2008).  Although structurally similar, 
OmpC and OmpF are known to facilitate differential rates of diffusion based on 
size with OmpC being the small molecular pore (<500 Da) and OmpF being the 
larger (<600 Da), respectively (Cowan et al., 1992). It has been shown that 
11 
 
selective expression of these porins allows E. coli cells to preferentially block the 
uptake of certain antibiotic compounds into the periplasm of Gram-negative 
bacteria (Pages et al., 2008). 
 The control of OmpC and OmpF expression has been an extensively 
studied phenomenon at both the genetic and biochemical levels (De la Cruz and 
Calva, 2010). The canonical model of OmpC and OmpF expression involves 
regulation of ompC and ompF transcription by the EnvZ/OmpR two-component 
regulatory system, responsive to extracellular osmolarity (Slauch et al., 1988, 
Slauch and Silhavy, 1989). EnvZ is the inner membrane-bound sensor-kinase 
which selectively phosphorylates OmpR (a DNA-binding transcription factor) in 
response to changes in the osmolarity of the surrounding medium (Forst et al., 
1989). The phosphorylated form of OmpR (OmpR-Pi or phospho-OmpR) is 
capable of binding to the PompF promoter with high affinity and activating 
transcription of ompF. As the level of OmpR-Pi increases with osmolarity, OmpR-
Pi is able to bind to low affinity sites in the PompC promoter resulting in 
upregulated transcription of ompC (Pratt and Silhavy, 1995). Likewise, OmpR-Pi 
binds to low affinity sites in PompF resulting in down-regulation of ompF 
transcription. The outcome is that under conditions of low osmolarity, cells 
preferentially express OmpF. And under conditions of high osmolarity, they 
express OmpC. Therefore this mechanism allows cells to exquisitely control the 
uptake of solutes from the external environment depending on the ratio of OmpC 
and OmpF expressed (Pratt et al., 1996). 
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 Additional regulatory factors aid in controlling the OmpC/F ratio. Of 
particular note is the small regulatory RNA (sRNA), MicF (Pratt et al., 1996, 
Vogel and Papenfort, 2006). The MicF sRNA is known to bind to the 5‟-
untranslated region (5‟-UTR) of the ompF mRNA thereby inhibiting translation of 
OmpF and effectively downregulating OmpF expression (Mizuno et al., 1984). 
MicF is expressed as the RNA poduct of the micF gene, divergently transcribed 
from the ompC gene (Mizuno et al., 1984). Due to their proximity to one another, 
micF and ompC share a common promoter control region, and consequently, 
both genes are regulated by OmpR-Pi (Matsuyama and Mizushima, 1985, Misra 
and Reeves, 1987). Additionally, the PmicF promoter is regulated by MarA, SoxS 
and Rob, products of the marRAB, soxRS, and rob systems (Cohen et al., 
1993b, Martin and Rosner, 2002, Bennik et al., 2000, Li and Demple, 1994). The 
presence of additional transcriptional regulators of micF allow for OmpF 
expression to be regulated independently of the canonical EnvZ/OmpR 
mechanism. 
 Numerous early observations noted changes in outer membrane porin 
composition on antibiotic exposure. Particularly, Cohen and coworkers noted that 
certain antibiotic resistant mutants (constitutive mutants in marRAB) resulted in 
down-regulated expression of OmpF (Cohen et al., 1988). A similar phenotype 
was observed during exposure of E. coli cells to salicylate (a toxic, aromatic acid) 
(Rosner et al., 1991). Both of these phenotypes were later found to be mediated 
by the repressive action of MicF (Cohen et al., 1993b, Rosner et al., 1991). Later 
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efforts have shown that all three of the marRAB, soxRS, and rob systems are 
capable of regulating micF transcription (Martin and Rosner, 2002). However, the 
relative magnitude of the contributions MarA, SoxS, and Rob have towards PmicF 
activation under antibiotic exposure remains unclear. 
 
Changes in cellular metabolism and expression of detoxifying enzymes. A 
strategy commonly employed during adaptation to toxic environments is the 
alteration of cellular metabolism and expression of detoxifying enzymes (Martin 
and Rosner, 2002, Viveiros et al., 2007, Kohanski et al., 2007, Pomposiello et al., 
2001, Greenberg et al., 1990). In the case of metabolic changes, very little is 
known about the exact changes that occur. However, systems-level 
transcriptional analysis does indicate that changes in gene expression of many 
metabolic enzymes changes during antibiotic exposure (Pomposiello et al., 2001, 
Martin and Rosner, 2002, Kohanski et al., 2007). Conversely, the action of 
detoxifying enzymes has been widely explored in vivo and in vitro. Collectively, 
these two changes in cellular enzymatic activity likely work in concert to alleviate 
the stress placed on cells burdened by excessive chemical efflux and 
perturbation of membrane integrity. 
 In the context of this study, an important metabolic change concerns the 
alteration of carbon flux in central metabolism. Based on microarray and gene 
expression analysis, it is well documented the expression of enzymes such as 
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glucose-6-phosphate dehydrogenase (the zwf gene product) are upregulated 
during exposure to toxic compounds such as salicylate and redox cycling 
antibiotics (Pomposiello et al., 2001). Glucose-6-phosphate dehydrogenase is an 
enzyme that converts glucose-6-phosphate to D-glucono-δ-lactone-6-phosphate, 
an entry-level intermediate into the Entner-Doudoroff (ED) and Pentose-
Phosphate (PP) pathways. Both the ED and PP pathways are known to generate 
more reducing equivalents of NAD(P)H during the oxidation of glucose than the 
Embden-Meyerhof-Parnas pathway. Based on the recent observations of 
Kohanski and coworkers who demonstrated a decrease in NADH levels of 
antibiotic exposed E. coli cells, an intriguing hypothesis is that upregulation of 
reducing pathways may alleviate stress imposed by changes in intracellular 
redox state (Kohanski et al., 2007). In a similar manner, two enzymes of the 
tricarboxylic acid (TCA) cycle, fumarase (fumC) and aconitase (acnB), are 
upregulated under similar conditions and believed to contribute to the same 
increase in cellular reducing power (Pomposiello et al., 2001, Martin and Rosner, 
2002). 
 Similarly, during exposure to similar families of antimicrobial compounds, it 
is known that detoxifying enzymes such as superoxide dismutase are expressed 
(Greenberg et al., 1990). Superoxide dismutases (SOD) catalyze the conversion 
of superoxide anions to hydrogen peroxide, thereby indirectly reducing the 
production of hydroxyl radicals and subsequent DNA damage. For the 
perspective of this study, the Mn2+ containing SOD (sodA) is upregulated during 
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treatment of cells with compounds such as salicylate and redox cycling 
antibiotics (Pomposiello et al., 2001).  
 In both of the above cases, the transcription of zwf and sodA are known to 
be directly influenced by the regulators MarA, SoxS, and Rob (Martin and 
Rosner, 2002). As abundantly clear in the preceding discussions, MarA, SoxS, 
and Rob are capable of regulating a large number of genes involved in the 
intrinsic multiple antibiotic resistance response. Numerous studies have 
employed transcriptional microarrays and transposon mutagenesis to better 
understand the genetic targets of MarA, SoxS, and Rob (Bennik et al., 2000, 
Ruiz and Levy, 2010, Pomposiello et al., 2001, Barbosa and Levy, 2000, Martin 
and Rosner, 2002). The following sections will provide an overview of the 
marRAB, soxRS, and rob genetic systems. 
 
1.4 The marRAB genetic system 
Discovered by Stuart Levy and coworkers during genetic screens for increased 
tolerance to the antibiotic tetracycline, the marRAB (multiple antibiotic resistance) 
operon has served as a model system in understanding regulated intrinsic 
antibiotic resistance in E. coli and related enteric γ-proteobacteria (George and 
Levy, 1983a, George and Levy, 1983b). The marRAB operon encodes genes for 
three proteins: MarR, MarA, and MarB. MarR and MarA are both DNA-binding, 
transcriptional regulatory proteins, while MarB is a protein of unknown function. 
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MarR and MarA are known to negatively and positively regulate, respectively, 
transcription of the PmarRAB promoter and thereby their own expression (Ariza et 
al., 1994, Martin et al., 1996, Martin et al., 1995, Martin and Rosner, 1995). 
Induction of mar-dependent antibiotic resistance is mediated by the expression of 
MarA which regulates numerous genes involved in the intrinsic resistance 
phenotype (Cohen et al., 1993a, Barbosa and Levy, 2000, Gambino et al., 1993). 
 As a foundational member of a large class of bacterial, DNA-binding 
proteins, MarR represses the expression of the marRAB operon through direct 
binding of two sites in the marRAB promoter (Martin and Rosner, 1995). 
Functional analysis and crystal structural evidence have demonstrated that MarR 
contains a conserved helix-turn-helix DNA binding motif and binds to palindromic 
and pseudopalidromic operator sequences as a homodimer (Alekshun et al., 
2001, Alekshun et al., 2000, Martin and Rosner, 1995).  
Like many of its homologues, MarR is capable of binding small molecules. 
Specifically, MarR has been observed bind salicylic acid, a weak aromatic acid, 
resulting in a loss of DNA binding ability and increased transcription of the 
marRAB operon (Martin and Rosner, 1995). Other studies have demonstrated 
chemicals such as menadione and plumbagin are capable of altering the DNA 
binding ability of MarR (Alekshun and Levy, 1999a).  In addition to the binding of 
small molecules, MarR has recently been observed to be bound by two proteins 
transketolase A (TrkA) and DNA gyrase A (GyrA) in E. coli (Domain et al., 2007, 
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Domain and Levy, 2010). Both enzymes have been implicated in the superoxide 
stress response, therefore, Domain and coworker have hypothesized that this 
enzyme serves a regulatory role in activating marRAB expression during 
oxidative stress. Genetic and biochemical evidence suggests the binding of these 
proteins to MarR causes a decrease in the ability of MarR to bind the marRAB 
promoter and subsequent increased expression of MarA (Domain and Levy, 
2010, Domain et al., 2007). 
 While MarR negatively regulates marRAB transcription, MarA is an 
activator of the marRAB operon and thus an autoactivator of its own expression 
(Martin et al., 1996). Likewise, MarA is directly involved in the positive and 
negative regulation of numerous downstream genetic targets involved in intrinsic 
resistance (Jair et al., 1995, Martin et al., 2008, Schneiders and Levy, 2006, Wall 
et al., 2009). At just over 15 kDa, MarA is a small regulatory protein and is a 
member of the AraC/XylS family of transcriptional regulators. Similar to other 
AraC/XylS family proteins, MarA contains two helix-turn-helix DNA binding 
domains (Rhee et al., 1998). Unlike many AraC/XylS regulators which often 
function as dimers, MarA binds to promoter regions as a monomer (Jair et al., 
1995). 
 Of the AraC/XylS regulatory proteins, MarA was the first to be fully 
crystallized in contact with DNA (Rhee et al., 1998). As result, extensive genetic 
and biochemical analysis has been performed to understand its involvement in 
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promoter activation and repression. Through biochemical and bioinformatic 
analysis, MarA is known to bind to a degenerate 19 base-pair sequence known 
as the marbox (AYNGCACNNWNNRYYAAAY) (Martin et al., 1999). In promoters 
regulated by MarA, the marbox has been found in only a few arrangements with 
respect to the -10 and -35 promoter regions (Martin et al., 1999). Like other 
transcription factors such as CRP, MarA is able to interact with RNA polymerase 
in an ambidextrous fashion (Jair et al., 1996a). By ambidextrous, it is meant that 
MarA can interact with RNA polymerase in two different ways depending on the 
arrangement of mar-box sites in the promoter creating two classes of promoters. 
For class I promoters, MarA binds to a marbox site upstream of the -35 region 
and requires contact with the C-terminal domain of the RNA polymerase α-
subunit (α-CTD) to activate or repress promoters. Conversely, in class II 
promoters MarA binds to marbox sequences overlapping the -35 region contact 
with the α-CTD is not required (Schneiders and Levy, 2006). 
 An additional feature of MarA interaction with promoter regions is that it is 
capable of activating or repressing transcription depending on its orientation and 
the location of the marbox site (Schneiders and Levy, 2006). In the above cases, 
the result of MarA interaction is the activation of transcription. For cases of 
transcriptional repression, a similar classification has been adopted. Type I 
repression occurs when MarA binds upstream of the -35 region and the N-
terminus contacts RNAP in a manner similar to class II activation. Unlike any of 
the prior cases, Type II repression is mediated by MarA binding between the -10 
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and -35 regions in a promoter, resulting in the occlusion of RNA polymerase 
binding, similar to the classical transcriptional repressor model. The net result is 
that the degeneracy of DNA binding and ambidextrous nature of interaction with 
RNA polymerase in promoters allows the targets of MarA regulation to be broad. 
This fact is directly reflected in the large number of genes regulated by MarA. 
 Apart from its interaction with DNA, MarA is itself regulated at the protein 
level. MarA has been found to be rapidly degraded by the ATP-dependent Lon 
protease (Griffith et al., 2004). Based on these findings it has been proposed that 
rapid degradation of MarA allows for MarA-dependent regulation to be quickly 
silenced once an appropriate chemical stress has been removed. Additionally, 
overexpression of MarA is known to result in loss of cellular viability (Griffith et 
al., 2004). It stands to reason then that rapid degradation of MarA may be a 
mechanism to prevent cytotoxicity caused by MarA. 
 
1.5 The soxRS system 
The soxRS (superoxide) system is a model system in understanding intracellular 
redox sensing in bacteria. Initially discovered by screens looking for regulators of 
nfo (Endonuclease IV) and mutants with increased tolerance to redox cycling 
compounds (Greenberg et al., 1990, Tsaneva and Weiss, 1990), the soxRS 
system encodes two DNA binding transcription factors, SoxR and SoxS. Both of 
these transcription factors are essential for the effective response to intracellular 
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superoxide generation. On the chromosome, the soxR and soxS genes are 
oriented and transcribed divergently to one another. 
 SoxR is a 2Fe2+-2S (iron-sulfur cluster) containing transcription factor of 
the MerR family of DNA binding proteins (Hidalgo et al., 1995, Hidalgo and 
Demple, 1994, Hidalgo and Demple, 1996). In solution, SoxR exists as a dimer 
with each monomer containing a single 2Fe2+-2S cluster (Hidalgo et al., 1995, 
Hidalgo and Demple, 1994). On oxidation of the iron-sulfur cluster, SoxR 
activates the PsoxS promoter resulting in upregulated expression of SoxS (Hidalgo 
et al., 1995, Hidalgo and Demple, 1994). The DNA binding affinity of SoxR is 
unaffected by its oxidation state, and therefore it is believed that SoxR remains 
bound to the soxRS control region at all times (Hidalgo et al., 1995, Hidalgo and 
Demple, 1996). A unique feature of SoxR in E. coli is that it is only known to 
regulate a small number of genes outside of soxS (Fuentes et al., 2001).  Other 
SoxR homologues in species such as Pseudomonas putida, Pseudomonas 
aeruginosa and Streptomyces coelicolor have been observed to possess 
extensive downstream regulons and to not work through another transcription 
factor such as SoxS (Dietrich et al., 2008, Park et al., 2006).  
 SoxS is a homolog of MarA and its properties in transcriptional regulation 
are nearly identical (Fawcett and Wolf, 1994, Jair et al., 1996a, Wood et al., 
1999). Additionally, SoxS binds DNA as a monomer (Wood et al., 1999). Like 
MarA, SoxS is targeted for rapid degradation by Lon protease which is believed 
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to be a mechanism for rapid SoxS inactivation (Griffith et al., 2004). Also, SoxS is 
known to negatively autoregulate its own expression through direct interaction 
with the PsoxS promoter (Nunoshiba et al., 1993b). Although MarA and SoxS do 
possess highly overlapping downstream regulons, it has been observed the 
relative affinity of these regulators for similar promoters is not equal resulting in 
differential transcriptional activation and repression (Martin et al., 2000).  
 The specific signal for oxidation of SoxR is not entirely clear, although it is 
known that intracellular superoxide and nitric oxide species can trigger SoxR 
activation in vivo (Greenberg et al., 1990, Nunoshiba et al., 1993a). Recently, 
Lee and coworkers have shown that electrons can be withdrawn from DNA-
bound SoxR to oxidized guanidine residues thereby oxidizing SoxR and 
activating SoxS expression (Lee et al., 2009). This implies that in addition to 
intracellular superoxides, DNA damage may play a larger role in soxRS 
activation. 
 
1.6 The rob system 
Rob (right origin binding) is a cryptic transcriptional regulator in E. coli discovered 
during a large-scale screen for proteins binding to the chromosomal origin of 
replication (oriC) (Skarstad et al., 1993, Ali Azam et al., 1999). Later studies 
determined, based on homology to both MarA and SoxS, that Rob is an 
AraC/XylS-like regulator capable of binding similar DNA sequences as MarA and 
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SoxS (Ariza et al., 1995, Li and Demple, 1996, Kwon et al., 2000). Although no 
apparent phenotype is known for a rob mutant, it is known, when overexpressed, 
to produce a similar multidrug resistance phenotype that is observed in mutants 
that constitutively express MarA or SoxS (Nakajima et al., 1995). Likewise, 
treatment of cells with chemicals such as decanoate and dipyridyl are known to 
produce a Rob-dependent resistance phenotype (Griffith et al., 2009, Rosenberg 
et al., 2003, Rosner et al., 2002). A point of divergence between Rob and 
Mara/SoxS is that Rob possesses an additional C-terminal domain believed to be 
involved in the binding of small molecules, not unlike other AraC/XylS-family 
regulators (Rosner et al., 2002, Kwon et al., 2000). 
 The DNA binding specificity and interaction with RNA polymerase 
between Rob and its homologues MarA and SoxS is extremely similar. In fact, 
numerous members of the marA and soxS regulons are activated or repressed 
by Rob (Bennik et al., 2000, Kwon et al., 2000, Ariza et al., 1995, Li and Demple, 
1996). Based on this evidence, this larger set of genes under MarA, SoxS and 
Rob regulation are known as the mar/sox/rob regulon.  
 Like MarA, Rob has been crystallized in contact with DNA (Kwon et al., 
2000). Although significant structural similarities exist between Rob and MarA, 
Rob has been found to contact DNA with only one helix-turn-helix motif whereas 
MarA does so with two (Kwon et al., 2000, Rhee et al., 1998). In addition, the 
regulatory properties of Rob in vivo do not appear to match those of Rob in vitro 
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– a point that will be further clarified. Specifically, Rob is expressed constitutively 
at high levels (~10,000 copies/cell) and remains inactive in absence of chemical 
stress whereas purified Rob is capable of activating transcription in the absence 
of any known chemical inducers (Li and Demple, 1996, Ariza et al., 1995, 
Skarstad et al., 1993, Ali Azam et al., 1999, Jair et al., 1996b). 
 Where Rob is most markedly different from MarA and SoxS concerns its 
regulation. For both MarA and SoxS, their expression is regulated at the 
transcriptional level. Rob, on the other hand, is constitutively expressed and is 
activated post-translationally (Rosner et al., 2002, Rosenberg et al., 2003, Griffith 
et al., 2009). Interestingly, recent work by Griffith and coworkers has shown that 
Rob regulates itself by a „sequestration-dispersion‟ mechanism (Griffith et al., 
2009). In the inactive state, Rob has been observed to form aggregrated clusters 
in the cytoplasm. On treatment with known Rob inducers such as decanoate and 
dipyridyl, Rob becomes homogenously dispersed throughout the cytoplasm. In 
elegant experiments with SoxS-Rob chimeras, Griffith and coworkers were also 
able to demonstrate that the „sequestration-dispersion‟ mechanism is dependent 
on the C-terminal domain of Rob. Based on these results, understanding the 
exact role of small molecule binding and possible other factors involved in Rob 
activation remains a continued point of interest. 
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1.7 Defining the mar/sox/rob regulon: beyond just genetic targets. 
The role of mar/sox/rob in cellular physiology. Numerous studies have 
defined an extensive list of regulatory targets that collectively define the 
mar/sox/rob regulon. Although many of these genes can be ascribed a 
discernable function for antibiotic resistance, many cannot (Martin and Rosner, 
2002). An attractive hypothesis, based on the targets that are well-characterized 
such as micF, sodA, or acrAB, might be that these systems have evolved for the 
purpose of responding to toxic environments such as those found in the 
presence of antibiotic producing soil bacteria. While this may in fact be true, 
limited data exists to fully support this hypothesis. An alternative perspective may 
be that these systems have evolved to combat intracellular problems that 
develop during the metabolism of diverse carbon sources or in certain nutrient 
limited conditions (Helling et al., 2002, Rosner and Martin, 2009, Piddock, 2006). 
 A key piece of evidence for the latter hypothesis comes from the recent 
work of Rosner and Martin who demonstrated that the mar/sox/rob regulon is 
upregulated in mutants lacking the outer membrane pore, TolC (Rosner and 
Martin, 2009). The authors conclude, based on their analysis, that the 
accumulation of intermediary metabolites is likely the source of gratuitous 
inducers of the marRAB, soxRS, and rob systems. In this dissertation, this 
analysis has been extended to look at a small number of aromatic metabolites as 
possible inducers, where it will be shown that these can serve as inducers of the 
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marRAB system. The general perspective of the following work will attempt to 
remain unbiased in the interpretation of results based on these differing opinions. 
 
 The role of mar/sox/rob in pathogenesis. An additional point interest for 
the mar/sox/rob network is its potential role in pathogenesis. Early assessments, 
based on work performed in Salmonella enterica serovar Typhimurium, has 
concluded that neither marRAB or soxRS are required for infection and 
colonization in a BALB/c murine model (Sulavik et al., 1997, Fang et al., 1997). 
Although these findings are indicative of the non-essentiality of MarA, SoxS, and 
Rob during intestinal infection, conflicting evidence exists for E. coli infection 
models. In particular, work by Casaz and coworkers has shown that mutants in 
marRAB, soxRS, and rob have attenuated virulence phenotypes in a murine 
urinary tract infection model (Casaz et al., 2006). These conflicting results 
underpin the need to understand the physiological and environmental factors in 
which the mar/sox/rob networks have evolved to respond. 
 
1.8 Conclusions 
This overview has brought to light the extensive amount of regulatory and 
biochemical information that is known about the mar/sox/rob regulon. Although, 
many details have been recorded, a shortcoming in our understanding of the 
mar/sox/rob regulon is an integrated, testable regulatory model. Through the use 
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of the model developed in the early portions of this work, the remaining chapters 
set out to use this model to answer a number of questions regarding mar/sox/rob 
regulon management and how the coordinated regulatory action of these 
systems is necessary for an appropriate antibiotic resistance response. 
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1.9 Figures and Tables 
 
Table 1.1. Genes know to be part of the mar/sox/rob regulon. Compiled from the 
EcoCyc Database (Keseler et al., 2009). 
 Known regulon member 
Gene marRAB soxRS Rob 
ybaO X   
acrAB X X X 
nfsA  X  
nfsB X   
fur  X  
ybiS   X 
fldA  X  
marRAB X X X 
poxB X X  
fumC X X X 
pqiAB X X  
putA X   
ptsG  X  
zwf X X X 
nfo X X X 
micF X X X 
ribA  X  
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Table 1.1 (Continued) 
inaA X X X 
zinT  X  
tolC X X X 
slp X   
mltF   X 
fldB  X  
hdeAB X   
waaY X X  
sodA X X X 
aslB   X 
fpr X X  
purA X   
rob X   
pgi  X  
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Figure 1.1. Defining differences in intrinsic (“inducible”) and acquired (“heritable”) 
forms of antibiotic resistance. 
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Chapter 2: Materials and Methods 
2.1 Bacterial strains, media, and growth conditions 
 All bacterial strains in this work are isogenic derivatives of Escherichia coli 
K-12 strain MG1655 or MC4100 and may be found in Table 2.1 with respective 
genotypes. For all propagation and genetic manipulations, strains were routinely 
grown in Luria-Bertrani (LB) media (10 g/l tryptone, 5 g/l yeast extract, 10 g/l 
NaCl with 15 g/l bacto agar for solid media) (Miller, 1992). Strains transformed 
with plasmid or linear DNA by electroporation or chemically induced competence 
were recovered in super optimal broth with catabolite repression (SOC) media 
(20 g/l tryptone, 5 g/l yeast extract, 0.5 g/l NaCl, 0.186 g/l KCl, 0.952 g/l MgCl2, 
20 mM glucose) (Miller, 1992). Unless otherwise indicated all experiments in this 
work were conducted in 3-(N-morpholino) propanesulfonic acid (MOPS) buffered 
minimal media (40 mM MOPS, 4 mM tricine, 9.5 mM NH4Cl, 0.276 mM K2SO4, 
5x10-4 mM CaCl2, 0.525 mM MgCl2, 50 mM NaCl, with micronutrients) using the 
formulation described by Neidhardt and coworkers supplemented with 20 mM 
glucose and 0.2% casamino acids as carbon sources with a final pH of 7.2, 
tryptone broth (10 g/l tryptone, 8 g/l NaCl), or Medium A (7g/l nutrient broth, 1 g/l 
yeast extract, 2 g/l glycerol, 3.7 g/l K2HPO4, 1.3 g/l KH2PO4) (Kawaji et al., 1979, 
Neidhardt et al., 1974, Miller, 1992). Strains were grown at 37oC with the 
exception of those harboring temperature-sensitive plasmids such as pKD46, 
pCP20, pINT-ts, or pAH123. Curing strains of these plasmids was typically 
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performed by overnight growth on solid LB media without antibiotic selection at 
42oC. Antibiotics were used at the following concentrations for plasmid 
propagation: 100 µg/ml ampicillin, 40 µg/ml kanamycin, and 20 µg/ml 
chloramphenicol. For chromosomal selection antibiotics were used the following 
concentrations: 20 µg/ml kanamycin, 10 µg/ml chloramphenicol, and 12.5 µg/ml 
tetracycline. All experiments using strains with chromosomal insertions or 
deletions were conducted in the absence of antibiotic selection. 
 
2.2 Reagents and chemical preparation 
Reagents and chemicals used in this study were purchased from Sigma-
Aldrich. Where possible, chemicals were dissolved in water and stored at -20oC. 
Stock concentrations of sodium salicylate (Sigma, S3007) and paraquat (methyl 
viologen dichloride hydrate) (Aldrich, 856177) were 0.5M and 50 mM, 
respectively. Due to poor solubility, sodium decanoate (Sigma, C4151) was 
supplemented to concentrated aliquots of inducing media immediately prior to 
use. Other organic acids used that were unavailable as sodium salts were 
brought into aqueous solution by titration with 5M NaOH until a pH of 7.0. 
Several aromatic acid solutions were subject to rapid oxidation and were 
prepared immediately prior to use to avoid prolonged storage. Nutritional 
supplements such as indole (Aldrich, I3408) were readily dissolved in dimethyl 
sulfoxide (DMSO). 
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2.3 Strain and plasmid construction 
All targeted insertions and deletions created in this work were constructed 
using the  λ-Red recombinase method of Datsenko and Wanner (Datsenko and 
Wanner, 2000). Briefly, deletion cassettes containing 40 base-pair (bp) regions of 
homologous DNA to sites on the chromosome were amplified by polymerase 
chain reaction (PCR). These products were purified using standards PCR clean-
up kits (Qiagen) or ethanol precipitation. Strains harboring the λ-Red 
recombinase expression vector, pKD46, were grown at 30oC in LB or SOB, 
induced with 0.2% arabinose, and made electrocompetent. DNA was 
transformed into these cells using an electroporator (BIO-RAD) (5 ms, 2.5 mV). 
Transformed cells were recovered for 2 to 4 hrs at 37oC in SOB media followed 
by plating on selective LB solid media. All deletions were transduced into their 
parent background, typically MG1655, using generalized P1vir transduction. 
All plasmids were constructed using standard methods (Sambrook, 2001). 
All PCR amplifications were made using MG1655 DNA and Phusion polymerase 
(New England Biolabs). Amplified DNA and vector DNA were treated with 
restriction endonuclease enzymes as per manufacturer‟s instructions (New 
England Biolabs). Ligated clones were transformed into recA hosts DH5α, 
DH5αZ1, or BW25141. Successful clones were verified by diagnostic PCR and 
DNA sequencing. 
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Single-copy transcriptional and translational fusions to YFP were made 
using the pVenus vector (Saini et al., 2009). All promoter fragments were cloned 
into the EcoRI and KpnI sites of pVenus. Subsequent clones were transformed 
into MG1655 harboring the pINT-ts helper plasmid to express Intλ and promote 
site specific recombination of the pVenus derivatives into the attλ site on the E. 
coli chromosome. Single-copy fusions were then transferred to other strains by 
P1vir generalized transduction.  
  
2.4 Protein purification 
Transcriptional regulatory proteins purified for in vitro assays were prepared by 
affinity chromatography using protein-protein fusions to either glutathione-S-
transferase (GST), 6xHistidine (6xHis) or 6xHistidine-Asparagine (6xHN) tags. 
Unless otherwise specified, proteins were purified using a ӒKTA Prime fast 
protein liquid chromatograph (FPLC) (GE Healthcare). Explicit procedures for 
individual proteins will be described in the following sections. 
 
Purification of MarR. To purify the GST-MarR fusion protein, BL21(DE3) cells 
harboring pGEX-marR were grown in 2-liter LB cultures at 37oC with 250 rpm 
shaking until an OD=0.7 as determined using a UV-1800 spectrophotometer 
(Shimadzu). Expression of GST-MarR was then induced by the addition of IPTG 
to 1 mM, followed by an additional 4 hrs of growth at 37oC. Cells were collected 
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and pelleted by centrifugation at 7000 x g for 10 minutes and were stored 
overnight at -80oC. The cell pellets were then resuspended in 3 ml of tris-buffered 
saline (TBS) (50 mM Tris, 150 mM NaCl, pH = 7.4) plus 1% Triton X-100 and 1 
mM dithiothreitol (DTT) for every 1 g of cell pellet. Resuspended cells were then 
disrupted by sonication (8 x 10s pulse). Cell debris was cleared by centrifugation 
at 10,000 x g for 10 minutes followed by 40,000 x g for 1 hr. 
Clarified cell lysate was then loaded onto a 5-ml GSTrap column (GE 
Healthcare) pre-equilibrated with TBS. The column was then washed with 5 bed 
volumes of TBS followed by elution with 20 ml of glutathione elution buffer (50 
mM Tris, 10 mM glutathione, pH = 8.0). The GST-MarR fusion was then dialyzed 
against 8 x 600 ml changes of  PreScission protease buffer (50 mM Tris, 100 mM 
NaCl, 1 mM EDTA, 1 mM DTT, pH = 8.0). The GST tag was then removed by 
proteolytic cleavage using 100 units of PreScission protease (GE Healthcare) for 
12 h at 4oC. The digested solution was then passed over a GSTrap column pre-
equilibrated with TBS to remove the cleaved GST and PreScission protease. The 
flow-through containing purified MarR was collected and dialyzed against 8 x 600 
ml of TBS. Protein concentration was determined using the bicinchoninic acid 
(BCA) reagent assay (Pierce) using bovine serum albumin (BSA) standards. 
Aliquot were frozen at -80oC and stored until use. 
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Purification of Rob. To purify the GST-Rob fusion, a nearly identical protocol to 
that described for GST-MarR was used with noted exceptions. The GST-Rob 
fusion was expressed from pGEX-rob in BL21(DE3) as outlined for GST-MarR. 
For purification steps, all buffers (TBS and GEB) were formulated with 0.5M 
NaCl. Likewise, after cleavage of GST from Rob by PreScission protease 
digestion and subsequent removal of GST and protease, Rob was dialyzed 
extensively (10 x 600 ml) a high salt storage buffer (50 mM Tris-HCl, 0.5 M NaCl, 
1 mM DTT, 20% glycerol, pH=8.0) and stored at -80oC. For experiments 
conducted in the presence of MarA, Rob was transferred into Buffer A (50 mM 
HEPES, 1 M NaCl, 1 mM DTT, 5 mM EDTA, 0.1% Triton X-100, pH=8.0) using a 
Micro Bio-Spin P-6 (BIO-RAD) buffer exchange column. Final proteins were 
determined using the BCA assay method using BSA standards after 
tricholoracetic acid (TCA) precipitation.  
  
Purification of MarA. Purification of MarA protein was performed using Ni-
affinity chromatography under batch, denaturing conditions in a manner similar to 
Jair and coworkers (Jair et al., 1995). MarA was expressed with a N-terminal 
6xHis tag from pET28a-marA in BL21(DE3). Cells were grown in 200 ml of LB 
media at 37oC and 250 rpm shaking to an OD=0.7 as measured using an 
UltroSpec 10 spectrophotometer (Amersham)  followed by induction with 0.5 mM 
IPTG. Cultures were grown for an additional two hours, followed by centrifugation 
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at 4000 rpm for 20 minutes at 20oC. The pellet was then washed once with 
phosphate buffered saline (PBS) (10 mM Na2HPO4, 2 mM KH2PO4, 138 mM 
NaCl, 2.7 mM KCl, pH=7.4), and repelleted The cell pellet was then frozen at -
80oC before any further steps.  
 Following cryogenic freezing, the pellet was thawed on ice and gently 
resuspended in 5 ml of Buffer B (100 mM NaH2PO4, 10 mM Tris-HCl, 8M Urea, 
pH=8.0) per gram of cell pellet. The cell suspension was then gently vortexed for 
5 minutes followed by incubation at room temperature for an additional 60 
minutes. Cell lysis was determined complete once the solution became 
translucent and viscous. Lysate was then clarified by centrifugation at 6,000 x g 
for 30 minutes. The clarified lysate was then transferred to a screw-cap 5 ml 
column, followed by the addition of 1 ml of 50% Ni-NTA resin (Qiagen) slurry per 
5 ml of cell extract that had been washed to remove storage ethanol and 
preincubated in Buffer B for 10 minutes. The mixture was then incubated at room 
temperature for 60 minutes with gentle agitation on a platform shaker to ensure 
uniform binding of 6xHis-MarA. 
 Following incubation, the Ni-NTA resin was allowed to settle and form a 
bed free of air bubbles in the column. The cell lysate was subsequently drained 
and collected from the column by gravity flow through the resin. After this step, 
the Ni-NTA resin was washed twice with 10 bed volumes of Buffer C (100 mM 
NaH2PO4, 10 mM Tris-HCl, 8M urea, pH=6.3). To remove non-specifically bound 
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products, the resin was washed four times with one bed volume of Buffer D (100 
mM NaH2PO4, 10 mM Tris-HCl, 8M urea, pH=5.9). Finally, denatured MarA was 
collected by acidic elution with four bed volumes of Buffer E (100 mM NaH2PO4, 
10 mM Tris-HCl, 8M urea, pH=4.7). MarA protein was then renatured by 
extensive (8 x 1 L), slow dialysis against Buffer A (50 mM HEPES, 1 M NaCl, 1 
mM DTT, 5 mM EDTA, 0.1% Triton X-100, pH=8.0) at 4oC. After renaturing, non-
soluble precipitate was removed by centrifugation at 10,000 x  g for 30 minutes. 
Renatured 6xHis-MarA was then concentrated 5X with a 10,000 MWCO 
centrifugal concentrator (Amicon). 
 Finally, the 6xHis tag was removed by digestion overnight at 4oC with 
Thrombin-argarose beads (RECOMT, Sigma-Aldrich) as per manufacturers 
instructions. Thrombin-agarose beads were removed by column filteration. 
Digested MarA was then dialyzed against Buffer A (6 x 1L) in a 8,000 MWCO 
membrane to remove the thrombin reaction buffer components and the cleaved 
6xHis tag. Complete removal of the tag was verified by SDS-PAGE and 
Coomassie staining. Final protein concentrations were determined by the BCA 
assay method using BSA standards after TCA precipitation. 
 
Purification of 6xHN-CRP. Purification of 6xHN-CRP was performed using Co-
affinity chromatography under batch, native conditions. CRP was expressed with 
a N-terminal 6xHN tag from pPROTet.E-crp-1 in LC100. Cells were grown in 50 
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ml of LB media at 37oC and 250 rpm shaking to an OD=0.7 as measured using 
an UltroSpec 10 spectrophotometer (Amersham)  followed by induction with 100 
µg/ml anhydrotetracycline (aTc). Cultures were grown for an additional three 
hours, followed by centrifugation at 4000 rpm for 20 minutes at 20oC. The pellet 
was then washed once with phosphate buffered saline (PBS) (10 mM Na2HPO4, 
2 mM KH2PO4, 138 mM NaCl, 2.7 mM KCl, pH=7.4), and repelleted. The cell 
pellet was then frozen at -80oC before any further steps. 
Cell pellets thawed and resuspended in 5 ml of TBS (50 mM Tris, 150 mM 
NaCl, pH=7.4) with 0.1% Triton X-100 per gram of cells. Resuspended cells were 
then disrupted by sonication (8 x 10s pulses). Cell debris was cleared by 
centrifugation at 10,000 x g for 30 minutes. The clarified extract was then 
incubated at 4oC for 1 hour with 1 ml of 50% TALON resin slurry (Clontech) that 
had been thoroughly washed and preincubated with TBS. Incubation was 
performed with gentle agitation on a platform shaker. 
Following incubation, the TALON resin mixture was transferred to a 5 ml 
spin column and allowed to settle and form a bed free of air bubbles in the 
column. The cell lysate was subsequently drained and collected from the column 
by gravity flow through the resin. Following this step, the resin was washed with 5 
bed volumes of wash buffer (50 mM Tris, 150 mM NaCl, 10 mM imidazole, 
pH=7.4) and eluted with 4 bed volumes of elution buffer (50 mM Tris, 150 mM 
NaCl, 150 mM imidazole, pH = 7.4). The eluted protein was then concentrated 
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5X with a 10,000 MWCO concentrator cassette (Amicon) followed by dialysis 
against CRP storage buffer (50 mM Tris, 100 mM KCl, 1 mM DTT, 1 mM EDTA, 
5% glycerol) . Final protein concentrations were determined by the BCA assay 
method after TCA precipitation. 
 
2.5 Electromobility shift assays 
Electromobility shift assays were conducted using a 150 basepair 
fragment of the marRAB promoter or a 186 base-pair fragment of the lac 
promoter generated by PCR using primers LC468 and LC257 or LC554 and 
LC555, respectively. Following PCR purification, DNA was quantified using a 
NanoDrop spectrophotometer (Thermo Scientific). For labeling reactions, 100 ng 
of DNA was labeled with 10 μCi of γP32-ATP with T4 polynucleotide kinase (New 
England Biolabs). Binding reactions were carried out in 20 μl of buffer (50 mM 
Tris, 1 mM EDTA, 50 mM NaCl, 75 ng/μl Herring Sperm DNA, 10% glycerol, 
pH=8.0) with indicated concentrations of inducers. For aromatic acids, 50 mM 
aqueous stock solutions were prepared by slowly buffering solutions to a pH = 
7.2 with NaOH. Reactions containing purified protein and labeled DNA were 
allowed to proceed at room temperature for 15 minutes for MarA, Rob, or 6xHN-
CRP binding reactions and 30 minutes for MarR binding reactions. Reaction 
products were then displayed on prerun 5% 0.5X TBE-buffered, acrylamide gels 
run at 150 V/10 mA for 30 minutes at 4oC. Gels were then transferred to filter 
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paper, dried, and imaged using a phosphor screen (Applied Biosystems) and 
Storm 840 PhosphorImager (Amersham). Image analysis was performed using 
ImageJ. 
 
2.6 Isothermal titration calorimetry 
All experiments were conducted using a MicroCal VP-ITC titration 
calorimeter preincubated to 25oC for at least one-hour prior to the start of 
experiments. MarR or Rob protein solutions were brought to a final concentration 
of 10 µM in TBS (150 mM NaCl for MarR, 500 mM for Rob) and pH was 
measured (typically between 7.2 and 7.4) using a Perkin-Elmer pH meter. Ligand 
solutions were prepared fresh in TBS, the pH of the solution was adjusted to that 
of the MarR or Rob solution, and the final concentration was brought to 10 mM. 
The 1.4 ml sample well was loaded with a blunt-end needle attached to a 5 ml 
Hamilton pipette making sure to introduce no air bubbles into the sample cell. 
Likewise, the injection syringe was filled and expelled with the 10 mM ligand 
solution twice prior to finally being filled and made free of any air bubbles. 
Experimental parameters used with the VP-ITC were 28 x 10 µl injections with 5 
minute spacings, 300 rpm stirring speed, and a reference power of 1 µcal/s. 
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2.7 Outer membrane protein preparation and display 
Outer membrane preparations were performed as described by Slauch and 
Silhavy (Slauch and Silhavy, 1989). Cells were grown overnight in Medium A, 
and subcultured 1:200 in 10 ml of fresh Medium A in 20 x 150 mm glass test 
tubes and grown at 37oC with 250 rpm shaking. High osmolarity conditions were 
created by increasing the NaCl concentration in Medium A to 200 mM. Cultures 
were grown to an OD=0.4 as determined by an UltroSpec 10 spectrophotometer 
(GE Healthcare) with 1 cm path length cuvettes. 
 Cultures were centrifuged at 4000 rpm for 20 minutes. The cell pellet was 
resuspended once in 10 ml of 30 mM Tris-HCl (pH=8.1), and centrifuged again 
for 10 minutes. The supernatant was thoroughly decanted and pellets were 
frozen at -80oC for at least 30 minutes. Following cryogenic freezing, the pellet 
was thawed and gently resuspended in 0.2 ml of 30 mM Tris-HCl/20% sucrose 
(pH=8.1), and placed on ice. Then, 20 µl of 10 mg/ml lysozyme (in 100 mM 
EDTA, pH=7.1), was added to the suspension, gently mixed, and allowed to 
incubate on ice for 30 minutes. Following lysozyme treatment, 1.5 ml of 3 mM 
EDTA (pH=7.1) was added, and the resulting spheroblasts were sonicated with a 
microtip sonicator using one, 20s pulse at room temperature. 
 The homogenized lysate (1.5 ml) was then centrifuged at 14,000 rpm for 
60 minutes. The supernatant was carefully decanted as to not dislodge the 
pelleted, insoluble membrane fraction. Membrane pellets were then resuspended 
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in 20 µl of Laemelli SDS sample buffer and boiled for 5 minutes at 100oC. The 
samples were then loaded and displayed on a 10% acrylamide:bisacrylamide 
(37.5:1) Tris Buffered SDS/6M urea gel run at 150V for 75 minutes at room 
temperature. Gels were fixed and stained with Coomassie Brilliant Blue R-250 
(Sigma) and scanned with a Hewlett Packard desktop scanner. Images were 
processed and analyzed using ImageJ. 
 
2.8 Transcriptional reporter assays 
96-well growth conditions. For the purposes of uniform growth, induction time 
and reporter expression assays, a deep well plate assay procedure was 
developed based on the assay of Griffith and Wolf (Griffith and Wolf, 2002) with 
modifications. Replicate overnight cultures were grown in 2 ml of media in 
16x100 mm glass test tubes. Each culture was subcultured in duplicate 1:200 
after which 0.45 ml was transferred to a single well of a polypropylene, 2.2 ml, 
deep, square, 96-well microtiter plate (VWR Scientific, ). The plates were then 
sealed with Breathe-Easy membranes (Sigma, Z380059) to reduce media 
evaporation and allow gas transfer for uniform aeration. Plates were 
subsequently placed on a high-speed microtiter plate shaker and agitated at 
1000 rpm at 37oC. Typical assays involved growth of cells to an OD=0.5 as 
determined using an UltroSpec 10 spectrophotometer (GE Healthcare). At this 
time 100 µl of media containing media with or without dissolved inducer was 
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rapidly added using a multichannel micropipettor. Following induction, plates 
were resealed with Breathe-Easy membrane and allowed to continue incubating 
at 1000 rpm and 37oC for an additional hour prior to measurements. 
 
Fluorescence measurements. Fluorescence and optical density measurements 
were made with a Tecan Safire2 plate reader. All measurements were made with 
a gain set at 125 and 515/530 nm (ex/em) filter setting for YFP fluorescence and 
440/480 nm (em/ex) for CFP fluorescence. Absorbance was set of 600 nm for 
optical density measurements. For cultures grown in MGC or Medium A 250 µl of 
culture was used for measurements. For cultures grown in LB, 150 µl of culture 
was used for measurements.  
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2.9 Tables 
Table 2.1. Bacterial strains used in this work. 
Strain Genotype Reference 
MG1655 F
-
 λ
-
 rph-1 rfb-50 CGSC 
MC4100 F- λ- [araD139] Δ(lacZYA-argF)U169 e14- flhD5301 Δ(fruK-yeiR)725(fruA25) relA1 
rpsL150(StrR) rbsR22 Δ(fimB-finE)632(::IS1) deoC1 
CGSC 
DH5α F- λ- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169 
hsdR17 
Lab stocks 
DH5αZ1 F- λ- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169 
hsdR17 attλ::(spcR lacIq tetR) 
(Lutz and Bujard, 1997) 
BW25141 F- λ- Δ(araB-araD)567 ΔlacZ4787(::rrnB-3) Δ(phoB-phoR)580 galU95 ΔuidA3::pir+ recA1 
ΔendA9::FRT rph-1 Δ(rhaB-rhaD)568 hsdR514 
CGSC, (Haldimann and 
Wanner, 2001) 
BL21(DE3) F- ompT gal dcm lon hsdS(rb-,rm-) λ(DE3 [lacI lacUV5-T7 gene1 ind1 sam7 nin5]) Lab stocks 
JW5249 F- λ- rph-1 Δ(araB-araD)567 ΔlacZ4787(::rrnB-3) Δ(rhaB-rhaD)568 hsdR514 marA752::kan CGSC, (Baba et al., 2006) 
JW4023 F- λ- rph-1 Δ(araB-araD)567 ΔlacZ4787(::rrnB-3) Δ(rhaB-rhaD)568 hsdR514 soxS756::kan CGSC, (Baba et al., 2006) 
JTG1078 F
-
 λ
-
 rph-1 rfb-50 INV(rrnD-rrnE)1 rpsL179 soxR105 zjc-2206::Tn10dKan CGSC, (Nunoshiba and 
Demple, 1994) 
MDG147 Φ(ompF
+
-yfp
+
)30 Φ(ompC
+
-cfp
+
)31 (Batchelor et al., 2005) 
LC100 F
-
 λ
-
 rph-1 rfb-50 attλ::(spcR lacI
q
 PT5/N25-tetR) (Chubiz and Rao, 2008) 
LC310 ∆rob::kan  
LC311 ∆soxRS::kan  
LC312 ∆marRAB::kan  
LC317 ∆marRAB::cm ∆soxRS::kan  
LC318 ∆rob::kan ∆soxRS::cm  
LC319 ∆rob::kan ∆marRAB::cm  
LC320 ∆rob::FRT  
LC321 ∆soxRS::FRT  
LC322 ∆rob::FRT ∆soxRS::FRT  
LC433 attλ::mar-'venus  
LC434 attλ::inaA-'venus  
LC439 attλ::micF-'venus  
LC440 attλ::rob-'venus  
LC441 attλ::soxS-'venus  
LC442 attλ::tolC-'venus  
LC454 ∆soxS756::kan   
LC455 ∆soxS756::kan ∆marA752::FRT  
LC456 ∆soxS756::kan ∆rob::FRT  
LC457 ∆soxS756::kan ∆marA752::FRT ∆rob::cm  
LC458 ∆soxS756::FRT  
LC459 ∆soxS756::FRT ∆marA752::FRT  
LC460 ∆soxS756::FRT ∆rob::FRT  
LC461 ∆soxS756::FRT attλ::venus  
LC462 ∆soxS756::FRT attλ::mar-venus  
LC463 ∆soxS756::FRT attλ::soxS-venus  
LC464 ∆soxS756::FRT attλ::rob-venus  
LC465 ∆soxS756::FRT attλ::inaA-venus  
LC466 ∆soxS756::FRT ∆rob::FRT attλ::venus  
LC467 ∆soxS756::FRT ∆rob::FRT attλ::mar-venus  
LC468 ∆soxS756::FRT ∆rob::FRT attλ::soxS-venus  
LC469 ∆soxS756::FRT ∆rob::FRT attλ::rob-venus  
LC470 ∆soxS756::FRT ∆rob::FRT attλ::inaA-venus  
LC471 ∆marA752::FRT  
LC472 ∆marA752::FRT ∆soxS756::FRT  
LC473 ∆marA752::FRT ∆rob::FRT  
LC474 ∆marA752::FRT ∆soxS756::FRT ∆rob::FRT  
LC475 ∆marA752::FRT attλ::mar-'venus  
LC476 ∆marA752::FRT attλ::soxS-'venus  
LC477 ∆marA752::FRT attλ::rob-'venus  
LC478 ∆marA752::FRT attλ::inaA-'venus  
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Table 2.1 (Continued) 
LC479 ∆marA752::FRT ∆soxS756::FRT attλ::mar-'venus  
LC480 ∆marA752::FRT ∆soxS756::FRT attλ::soxS-'venus  
LC481 ∆marA752::FRT ∆soxS756::FRT attλ::rob-'venus  
LC482 ∆marA752::FRT ∆soxS756::FRT attλ::inaA-'venus  
LC483 ∆marA752::FRT ∆rob::FRT attλ::mar-'venus  
LC484 ∆marA752::FRT ∆rob::FRT attλ::soxS-'venus  
LC485 ∆marA752::FRT ∆rob::FRT attλ::rob-'venus  
LC486 ∆marA752::FRT ∆rob::FRT attλ::inaA-'venus  
LC487 ∆marA752::FRT  ∆soxS756::FRT ∆rob::FRT attλ::mar-'venus  
LC488 ∆marA752::FRT  ∆soxS756::FRT ∆rob::FRT attλ::soxS-'venus  
LC489 ∆marA752::FRT  ∆soxS756::FRT ∆rob::FRT attλ::rob-'venus  
LC490 ∆marA752::FRT  ∆soxS756::FRT ∆rob::FRT attλ::inaA-'venus  
LC492 ∆rob::FRT attλ::mar-'venus  
LC493 ∆rob::FRT attλ::soxS-'venus  
LC494 ∆rob::FRT attλ::rob-'venus  
LC495 ∆rob::FRT attλ::inaA-'venus  
LC496 ∆marRAB::FRT  
LC497 ∆marRAB::FRT ∆soxRS::FRT  
LC539 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT  
LC551 ∆tolC::cat  
LC567 ∆entCEBAH::cat  
LC614 ΔtolC::FRT  
LC617 ΔtolC::FRT Δent::cat  
LC621 ΔtolC::FRT attλ::(mar'-venus oriR6K kan)  
LC623 ΔtolC::FRT attλ::(micF'-venus oriR6K kan)  
LC627 ΔtolC::FRT Δent::FRT  
LC634 ΔtolC::FRT Δent::FRT attλ::(mar'-venus oriR6K kan)  
LC665 ∆marRAB::FRT attλ::(mar'-venus oriR6K kan)  
LC666 ∆soxRS::FRT attλ::(mar'-venus oriR6K kan)  
LC667 ∆rob::FRT attλ::(mar'-venus oriR6K kan)  
LC668 ∆marRAB::FRT ∆soxRS::FRT attλ::(mar'-venus oriR6K kan)  
LC669 ∆rob::FRT ∆soxRS::FRT attλ::(mar'-venus oriR6K kan)  
LC670 ∆marRAB::FRT ∆rob::FRT attλ::(mar'-venus oriR6K kan)  
LC671 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(mar'-venus oriR6K kan)  
LC672 ∆marRAB::FRT attλ::(soxS'-venus oriR6K kan)  
LC673 ∆soxRS::FRT attλ::(soxS'-venus oriR6K kan)  
LC674 ∆rob::FRT attλ::(soxS'-venus oriR6K kan)  
LC675 ∆marRAB::FRT ∆soxRS::FRT attλ::(soxS'-venus oriR6K kan)  
LC676 ∆rob::FRT ∆soxRS::FRT attλ::(soxS'-venus oriR6K kan)  
LC677 ∆marRAB::FRT ∆rob::FRT attλ::(soxS'-venus oriR6K kan)  
LC678 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(soxS'-venus oriR6K kan)  
LC679 ∆marRAB::FRT attλ::(rob'-venus oriR6K kan)  
LC680 ∆soxRS::FRT attλ::(rob'-venus oriR6K kan)  
LC681 ∆rob::FRT attλ::(rob'-venus oriR6K kan)  
LC682 ∆marRAB::FRT ∆soxRS::FRT attλ::(rob'-venus oriR6K kan)  
LC683 ∆rob::FRT ∆soxRS::FRT attλ::(rob'-venus oriR6K kan)  
LC684 ∆marRAB::FRT ∆rob::FRT attλ::(rob'-venus oriR6K kan)  
LC685 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(rob'-venus oriR6K kan)  
LC686 ∆marRAB::FRT attλ::(inaA'-venus oriR6K kan)  
LC687 ∆soxRS::FRT attλ::(inaA'-venus oriR6K kan)  
LC688 ∆rob::FRT attλ::(inaA'-venus oriR6K kan)  
LC689 ∆marRAB::FRT ∆soxRS::FRT attλ::(inaA'-venus oriR6K kan)  
LC690 ∆rob::FRT ∆soxRS::FRT attλ::(inaA'-venus oriR6K kan)  
LC691 ∆marRAB::FRT ∆rob::FRT attλ::(inaA'-venus oriR6K kan)  
LC692 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(inaA'-venus oriR6K kan)  
LC693 ∆marRAB::FRT attλ::(micF'-venus oriR6K kan)  
LC694 ∆soxRS::FRT attλ::(micF'-venus oriR6K kan)  
LC695 ∆rob::FRT attλ::(micF'-venus oriR6K kan)  
LC696 ∆marRAB::FRT ∆soxRS::FRT attλ::(micF'-venus oriR6K kan)  
LC697 ∆rob::FRT ∆soxRS::FRT attλ::(micF'-venus oriR6K kan)  
LC698 ∆marRAB::FRT ∆rob::FRT attλ::(micF'-venus oriR6K kan)  
LC699 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(micF'-venus oriR6K kan)  
LC700 ∆marRAB::FRT ∆rob::FRT  
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  LC730 soxS::cat  
LC731 JTG1078 soxS::cat  
LC741 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR  
LC742 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR105  
LC756 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR attλ::(mar'-venus oriR6K kan)  
LC757 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR attλ::(soxS'-venus oriR6K kan)  
LC758 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR attλ::(rob'-venus oriR6K kan)  
LC759 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR attλ::(inaA'-venus oriR6K kan)  
LC760 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR105 attλ::(mar'-venus oriR6K kan)  
LC761 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR105 attλ::(soxS'-venus oriR6K kan)  
LC762 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR105 attλ::(rob'-venus oriR6K kan)  
LC763 ∆marRAB::FRT ∆rob::FRT soxS::cat soxR105 attλ::(inaA'-venus oriR6K kan)  
LC794 soxS::cat soxR attλ::(soxS'-venus oriR6K kan)  
LC795 soxS::cat soxR105 attλ::(soxS'-venus oriR6K kan)  
LC910 ∆ompR::cat  
LC951 ∆rob::FRT soxS::cat soxR105 attλ::(soxS'-venus oriR6K kan)  
LC963 ∆marRAB::FRT soxS::cat soxR105 attλ::(soxS'-venus oriR6K kan)  
LC998 ∆trpD::FRT  
LC1031 ∆rpoS::FRT attλ::(mar'-venus oriR6K kan)  
LC1032 ∆rpoS::FRT attλ::(inaA'-venus oriR6K kan)  
LC1054 ∆rob::FRT ∆tolC::cat  
LC1055 ∆soxRS::FRT ∆tolC::cat  
LC1056 ∆marRAB::FRT ∆tolC::cat  
LC1057 LC539 ∆tolC::cat  
LC1080 ∆micF::kan  
LC1081 ∆tolC::FRT ∆micF::kan  
LC1082 LC539 ∆micF::kan  
LC1091 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(mar'-venus oriR6K kan) ∆crp::cat  
LC1095 ∆crp::cat  
LC1096 LC539 attλ::(micC'-venus oriR6K kan)  
LC1097 LC539 attλ::(ompF'-venus oriR6K kan)  
LC1099 LC539 attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1106 attλ::(ompF'-venus oriR6K kan)  
LC1108 attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1109 ∆micF::FRT  
LC1110 LC539 ∆micF::FRT  
LC1117 ∆tolC::FRT ∆micF::FRT  
LC1126 ∆entA::cat  
LC1127 ∆entF::cat  
LC1128 ∆entE::cat  
LC1129 ∆trpE::cat  
LC1130 ∆entD::FRT attλ::(mar'-venus oriR6K kan)  
LC1131 ∆entD::FRT ∆tolC::FRT attλ::(mar'-venus oriR6K kan)  
LC1132 ∆trpD::FRT attλ::(mar'-venus oriR6K kan)  
LC1133 ∆trpD::FRT ∆tolC::FRT attλ::(mar'-venus oriR6K kan)  
LC1136 ∆entA::cat attλ::(mar'-venus oriR6K kan)  
LC1137 ∆entF::cat attλ::(mar'-venus oriR6K kan)  
LC1139 ∆trpE::cat attλ::(mar'-venus oriR6K kan)  
LC1142 ∆tolC::FRT ∆entA::cat attλ::(mar'-venus oriR6K kan)  
LC1143 ∆tolC::FRT ∆entF::cat attλ::(mar'-venus oriR6K kan)  
LC1145 ∆tolC::FRT ∆trpE::cat attλ::(mar'-venus oriR6K kan)  
LC1148 ∆entA::FRT attλ::(mar'-venus oriR6K kan)  
LC1149 ∆entF::FRT attλ::(mar'-venus oriR6K kan)  
LC1151 ∆trpE::FRT attλ::(mar'-venus oriR6K kan)  
LC1152 ∆tolC::FRT ∆entA::FRT attλ::(mar'-venus oriR6K kan)  
LC1153 ∆tolC::FRT ∆entF::FRT attλ::(mar'-venus oriR6K kan)  
LC1155 ∆tolC::FRT ∆trpE::FRT attλ::(mar'-venus oriR6K kan)  
LC1160 ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(mar'-venus oriR6K kan) ∆crp::FRT  
LC1164 LC539 ∆tolC::FRT  
LC1165 ∆marRAB::FRT ∆tolC::FRT  
LC1166 ∆soxRS::FRT ∆tolC::FRT  
LC1167 ∆rob::FRT ∆tolC::FRT  
LC1172 LC1160/pPROTetE  
LC1173 LC1160/pPROTetE-crp-1  
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LC1178 ∆tolC::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1179 ∆tolC::FRT ∆marRAB::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1180 ∆tolC::FRT ∆soxRS::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1181 ∆tolC::FRT ∆rob::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1182 ∆tolC::FRT ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1183 ∆tolC::FRT ∆micF::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1184 ∆tolC::FRT attλ::(ompF'-venus oriR6K kan)  
LC1185 ∆tolC::FRT ∆marRAB::FRT attλ::(ompF'-venus oriR6K kan)  
LC1186 ∆tolC::FRT ∆soxRS::FRT attλ::(ompF'-venus oriR6K kan)  
LC1187 ∆tolC::FRT ∆rob::FRT attλ::(ompF'-venus oriR6K kan)  
LC1188 ∆tolC::FRT ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(ompF'-venus oriR6K kan)  
LC1189 ∆tolC::FRT ∆micF::FRT attλ::(ompF'-venus oriR6K kan)  
LC1190 ∆tolC::FRT ∆marRAB::FRT attλ::(micF'-venus oriR6K kan)  
LC1191 ∆tolC::FRT ∆soxRS::FRT attλ::(micF'-venus oriR6K kan)  
LC1192 ∆tolC::FRT ∆rob::FRT attλ::(micF'-'venus oriR6K kan)  
LC1193 ∆tolC::FRT ∆marRAB::FRT ∆soxRS::FRT ∆rob::FRT attλ::(micF'-venus oriR6K kan)  
LC1194 ∆tolC::FRT ∆micF::FRT attλ::(micF'-venus oriR6K kan)  
LC1200 ∆marRAB::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1201 ∆soxRS::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1202 ∆rob::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1203 ∆marRAB::FRT ∆soxRS::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1204 ∆rob::FRT ∆soxRS::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1205 ∆marRAB::FRT ∆rob::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1206 ∆micF::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1207 ∆marRAB::FRT attλ::(ompF'-venus oriR6K kan)  
LC1208 ∆soxRS::FRT attλ::(ompF'-venus oriR6K kan)  
LC1209 ∆rob::FRT attλ::(ompF'-venus oriR6K kan)  
LC1210 ∆marRAB::FRT ∆soxRS::FRT attλ::(ompF'-venus oriR6K kan)  
LC1211 ∆rob::FRT ∆soxRS::FRT attλ::(ompF'-venus oriR6K kan)  
LC1212 ∆marRAB::FRT ∆rob::FRT attλ::(ompF'-venus oriR6K kan)  
LC1213 ∆micF::FRT attλ::(ompF'-venus oriR6K kan)  
LC1214 ∆micF::FRT attλ::(micF'-venus oriR6K kan)  
LC1222 ∆marRAB::FRT ∆micF::FRT  
LC1223 ∆rob::FRT ∆micF::FRT  
LC1224 ∆marRAB::FRT ∆rob::FRT ∆micF::FRT  
LC1225 ∆marRAB::FRT ∆micF::FRT attλ::(ompF'-venus oriR6K kan)  
LC1226 ∆rob::FRT ∆micF::FRT attλ::(ompF'-venus oriR6K kan)  
LC1227 ∆marRAB::FRT ∆rob::FRT ∆micF::FRT attλ::(ompF'-venus oriR6K kan)  
LC1228 ∆marRAB::FRT ∆micF::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1229 ∆rob::FRT ∆micF::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1230 ∆marRAB::FRT ∆rob::FRT ∆micF::FRT attλ::(ompF'-'venus(hyb) oriR6K kan)  
LC1231 ∆marRAB::FRT ∆micF::FRT attλ::(micF'-venus oriR6K kan)  
LC1232 ∆rob::FRT ∆micF::FRT attλ::(micF'-venus oriR6K kan)  
LC1233 ∆marRAB::FRT ∆rob::FRT ∆micF::FRT attλ::(micF'-venus oriR6K kan)  
LC1239 MDG147 ∆marRAB::kan  
LC1240 MDG147 ∆rob::cat  
LC1241 MDG147 ∆marRAB::kan ∆rob::cat  
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Table 2.2. Plasmids used in this work. 
Name Relevant characteristics Reference 
pKD46 bla PBAD gam bet exo pSC101 ori(ts) (Datsenko and Wanner, 2000) 
pCP20 bla cat cI857 λPR‟-flp pSC101 ori(ts) (Datsenko and Wanner, 2000) 
pKD3 bla rgnB FRT cat FRT oriR6K 
(Datsenko and Wanner, 2000) 
pKD4 bla rgnB FRT aph FRT oriR6K 
(Datsenko and Wanner, 2000) 
pKD13 bla rgnB FRT aph FRT oriR6K 
(Datsenko and Wanner, 2000) 
pBAD30 bla araC ParaBAD oriM13 p15A ori (Guzman et al., 1995) 
pBAD30-marA pBAD30::marA  
pBAD30-soxS pBAD30::soxS  
pBAD30-rob pBAD30::rob   
pPROTet.E133 cat PLtetO-1‟-6xHN-MCS ColE1 ori Clontech 
pPROTet.E-crp-1 pPROTet.E133::crp  
pGEX-6P-2 bla lacI
q
 Plac‟-gst-MCS pMB1 ori GE Healthcare 
pGEX-marR pGEX-6P-2::marR  
pGEX-rob pGEX-6P-2::rob  
pET28a(+) kan PT7lac‟-6xHis-MCS lacI
q
 pMB1 ori Novagen 
pET28a-marA pET28a(+)::marA  
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Table 2.2 (Continued) 
pVenus kan rgnB yfp(Venus) t0 oriR6K 
(Saini et al., 2009) 
pVenus-mar pVenus::PmarRAB  
pVenus-soxS pVenus::PsoxS  
pVenus-rob pVenus::Prob  
pVenus-inaA pVenus::PinaA  
pVenus-micF pVenus::PmicF  
pVenus-ompF pVenus::PompF  
pVenus-FY pVenus::ompF’-‘yfp(hyb)  
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Chapter 3: A feed-forward regulatory network model for the 
mar/sox/rob regulon of Escherichia coli K-12 
3.1 Introduction 
Bacterial resistance to antibiotics has been a continuing clinical and public 
health problem for decades. Of the observed mechanisms causing antibiotic 
resistance there are two primary modes: acquired resistance and intrinsic 
resistance (Alekshun and Levy, 2007, Nikaido, 2009). Acquired resistance is 
conferred to bacteria through beneficial chromosomal mutations or more 
commonly the acquisition of genes encoding antibiotic resistance determinants. 
Typically, these determinants are carried on mobile genetic elements such as 
plasmids and transposons (Nikaido, 2009, Alekshun and Levy, 2007, Levy and 
Marshall, 2004). Intrinsic resistance, on the other hand, is a process where 
bacterial cells can initiate changes in cellular metabolism and physiology to 
survive exposure to antimicrobial compounds (Alekshun and Levy, 2007, 
Nikaido, 2009). A defining feature of intrinsic resistance is that the genes 
required for this phenotype are naturally occurring in the host‟s genome. 
In the enteric bacterium Escherichia coli, a number of naturally existing 
systems have been implicated in facilitating intrinsic resistance to a broad 
spectrum of antimicrobial compounds. Among these are multidrug efflux pumps, 
outer-membrane porins, superoxide dismutases, and metabolic enzymes 
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(Nikaido, 2009, Alekshun and Levy, 2007, De la Cruz and Calva, 2010). Although 
many of these systems can independently confer resistance, it is more common 
that they are used in concert to orchestrate a coordinated response. The ability to 
coordinate genetic regulation of such diverse genetic targets is mediated by three 
regulators in E. coli: MarA, SoxS, and Rob (Miller and Sulavik, 1996, Martin and 
Rosner, 2002). 
 MarA, SoxS, and Rob are three homologous, AraC/XylS-like regulatory 
proteins involved in the regulation of over 60 genes during exposure to 
antimicrobial compounds (Barbosa and Levy, 2000, Martin and Rosner, 2002, 
Gallegos et al., 1997). As a result of this homology, these three proteins bind to a 
similar, degenerate DNA sequence in promoters leading to the activation or 
repression of associated genetic targets (Martin et al., 1999, Jair et al., 1995, Jair 
et al., 1996b, Li and Demple, 1994). Numerous genetic and biochemical studies 
have identified a common set of regulated genes referred to as the 
marA/soxS/rob regulon. Despite the overlapping nature of the marA/soxS/rob 
regulon, MarA, SoxS, and Rob have been observed to differentially regulate 
activation and repression of promoters (Martin et al., 2000). This is presumably 
due to differing affinities of each protein for common DNA binding sites. 
In addition to the regulation of downstream genetic targets, MarA, SoxS, 
and Rob are themselves regulated, albeit by dissimilar mechanisms. MarA 
expression is driven from the tri-cistronic marRAB operon that, including MarA, 
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encodes genes for MarR and MarB (Cohen et al., 1993a). MarR is the repressor 
of the marRAB operon while MarA is an autoactivator (Seoane and Levy, 1995, 
Ariza et al., 1994, Martin and Rosner, 1995, Martin et al., 1996). MarB is a 
protein of unknown function. Up-regulation of the marRAB operon can be 
mediated through binding aromatic compounds such as salicylic acid to MarR 
resulting in decreased binding affinity of MarR for the marRAB promoter (Martin 
and Rosner, 1995, Cohen et al., 1993b, Alekshun and Levy, 1999a, Seoane and 
Levy, 1995). Recent evidence also suggests that proteins involved in metabolism 
and DNA replication are able to interact with MarR resulting in marRAB activation 
(Domain et al., 2007, Domain and Levy, 2010). A unique feature of the marRAB 
system is that both an autorepressor and an autoactivator are encoded in the 
same operon. This is thought to allow rapid and sensitive response to 
appropriate environmental stimuli (Martin and Rosner, 2004). 
Expression of SoxS is regulated by the redox-sensing regulator, SoxR 
(Wu and Weiss, 1992, Nunoshiba et al., 1992). SoxR is a Fe-S cluster containing 
transcriptional regulator found throughout many bacterial species (Park et al., 
2006, Hidalgo et al., 1995, Hidalgo and Demple, 1994). On oxidation of the Fe-S 
cluster in the presence of superoxides and redox-cycling compounds such as 
paraquat, SoxR increases transcription of soxS (Hidalgo et al., 1995, Hidalgo and 
Demple, 1996). Both SoxR and SoxS autorepress their own expression, 
respectively, affording the soxRS system a rapid shut off mechanism after the 
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presence of oxidative chemical species have diminished (Nunoshiba et al., 
1993b, Hidalgo et al., 1998).  
While the regulation of MarA and SoxS expression is at the transcriptional 
level, Rob is constitutively expressed (~10,000 copies per cell) and is activated 
post-translationally (Skarstad et al., 1993, Rosner et al., 2002). On binding to 
chemicals such as dipyridyl, deoxycholate, and decanoate to the C-terminal 
domain, Rob undergoes a conformational change from an inactive to active form 
(Rosenberg et al., 2003, Rosner et al., 2002, Griffith et al., 2009). In the inactive 
state Rob has been observed to form localized aggregates in the cytoplasm, and 
on activation becomes homogenously dispersed in the intracellular space, 
leading to a proposed „sequestration-dispersion‟ model (Griffith et al., 2009, Ali 
Azam et al., 1999). 
Although these systems exhibit divergent self-regulatory mechanisms, 
MarA, SoxS, and Rob can also transcriptionally regulate one another. MarA and 
SoxS, in addition to autoregulating their own expression, have been observed to 
repress transcription of rob (Michan et al., 2002, McMurry and Levy, 2010, 
Schneiders and Levy, 2006). Likewise, SoxS and Rob have been observed to 
bind and activate the marRAB promoter (Miller et al., 1994, Martin and Rosner, 
1997, Martin et al., 1996). The result is a complex regulatory network capable of 
significant cross-regulation as well as downstream regulation. 
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Extensive, independent examination of these systems and their genetic 
targets has defined a complex regulatory system capable of responding to a 
variety of chemical species. However, an integrated model of the interconnected 
relationship of the marRAB, soxRS, and rob systems and their associated 
genetic responses has not been well established. Additionally, a number of 
global regulators have recently been implicated as activators of the marRAB 
system and ultimately MarA expression (Ruiz and Levy, 2010, Martin and 
Rosner, 1997, Cohen et al., 1993b). The goal of this chapter is to rigorously 
define the genetic relationship between the marRAB, soxRS, and rob systems to 
provide a more accurate picture of the physiological magnitude of genetic cross-
talk in the mar/sox/rob regulon. Likewise, we explore two global regulators, cAMP 
receptor protein (CRP) and the stationary phase sigma factor (RpoS), as 
regulators of marRAB transcription. 
 
3.2 Results 
The marRAB, soxRS, and rob systems form an integrated regulon. A 
number of studies have previous shown that the marRAB, soxRS, and rob 
systems are subject to transcriptional cross-talk (Michan et al., 2002, Schneiders 
and Levy, 2006, Miller et al., 1994, Martin and Rosner, 1997). Specifically, both 
SoxS and Rob have been shown to activate the marRAB promoter, whereas 
SoxS and MarA have been shown to negatively regulate the rob promoter. Taken 
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together with corresponding biochemical evidence, it has been suggested that 
these systems are capable of regulating one another forming a fully integrated 
regulatory circuit (Schneiders and Levy, 2006, Ruiz and Levy, 2010). To verify 
this assertion, we constructed a genetic background in which we ectopically 
expressed each of the regulators MarA, SoxS, and Rob from the arabinose-
inducible promoter on a plasmid and monitored gene expression using 
transcriptional fusions of the marRAB, soxS, and rob promoters to the fast-folding 
yfp variant, Venus (Nagai et al., 2002). The genetic background used lacked the 
regulatory components marR, marA, soxS, and rob in addition to harboring a 
constitutively active SoxR mutant, soxR105 (Nunoshiba and Demple, 1994). As 
PsoxS promoter activation is dependent on the oxidation of SoxR, use of a 
constitutively active (or oxidized) mutant allowed the regulatory role of MarA, 
SoxS, and Rob on soxS gene expression to be examined without the use of 
additional inducing chemicals.  
 As shown in Figure 3.1A, we found that MarA, SoxS, and Rob could regulate 
the PmarR, PsoxS, and Prob promoters in a sign-consistent manner. By this, we 
mean that these three regulators had the same effect on the activity of each 
individual promoter, albeit with varying intensities. Consistent with previous 
studies, we found that MarA, SoxS, and Rob are all activators of the PmarR 
promoter (Miller et al., 1994, Martin and Rosner, 1997, Martin et al., 1996). 
Interestingly, Rob appears to have a greater ability to activate the PmarR promoter 
than either MarA or SoxS (approximately 1.5 fold higher). This is likely due to the 
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differences in relative stability of the three regulators as well as their relative 
levels of expression from the plasmid vector (Griffith et al., 2009, Griffith et al., 
2004). Likewise, Rob is able to negatively autoregulate its own expression to 
similar levels as the negative regulation imposed by MarA and SoxS on the Prob 
promoter. Finally, both MarA and Rob are able to negatively regulate PsoxS 
transcription, although to a lesser degree than SoxS. Based on these results, we 
are able to propose the following model for the integrated mar/sox/rob regulatory 
network presented in Figure 3.1B.  
 
The effects of transcriptional crosstalk on the activation of the mar, sox, 
and rob systems to their canonical inducers.  We next explored the 
physiological magnitude of crosstalk in the mar/sox/rob network. The model 
presented in Figure 3.1B suggests that all three regulators MarA, SoxS and Rob 
are capable of modulating the activity of each of the respective PmarR, PsoxS, and 
Prob promoters. To directly test this model, we measured the transcriptional 
activity of these promoters in genetic backgrounds missing all but one of the 
regulatory systems. This allowed for cross-regulatory effects to be quantified for 
each system where MarA, SoxS, and Rob are expressed at their physiologically 
relevant levels. Expression of MarA and SoxS, and activation of Rob, was 
induced by the addition of salicylate, paraquat or decanoate, respectively, to mid-
log phase cultures. 
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 Consistent with the proposed model, and previous observations, both 
SoxS and Rob are capable of activating the PmarR promoter under physiological 
conditions (Figure 3.2A). Although SoxS and Rob are both activators of PmarR, 
these data clearly demonstrate that their relative effects are not equivalent. 
Presumably, this is due to differences in concentration and stability (Griffith et al., 
2004, Martin et al., 2008). Previous studies have shown that Rob is present at 
10,000 copies per cell whereas SoxS is present at approximately 2,500 
molecules per cell (Griffith et al., 2002, Skarstad et al., 1993). Additionally, SoxS 
is rapidly degraded by Lon protease whereas Rob is protected from degradation 
by its C-terminal domain in the „sequestered‟ state (Griffith et al., 2009, Griffith et 
al., 2004). Moreover, promoters of the mar/sox/rob regulon have been recently 
shown to respond proportionally to the amount of MarA and SoxS, termed 
„commensurate activation‟ (Martin et al., 2008). Finally, the regulators MarA, 
SoxS and Rob have been observed to possess differential binding affinities to 
regulon promoters (Martin et al., 2000). Particularly, in vitro evidence suggests 
that Rob binds to the PmarR promoter with higher affinity than MarA or SoxS 
(Martin et al., 2002).  Taken together, we suggest that Rob is a more abundant, 
stronger transcriptional activator than SoxS at the PmarR promoter. 
 Examination of the effects on the PsoxS promoter yielded unexpected 
results given the proposed model. Under inducing conditions of either MarA 
expression or Rob activation, we observed no decrease in PsoxS transcription 
(Figure 3.2B). As transcription of PsoxS was constitutively activated by the 
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presence of a constitutively active SoxR (soxR105), as to alleviate any additional 
stress imposed by multiple inducing compounds, we conclude that under 
physiological conditions MarA and Rob do not significantly decrease PsoxS 
activity. 
 Finally, we found that both MarA and SoxS are both capable of down-
regulating Prob activity in vivo although to differing degrees (Figure 3.2C). 
Previous biochemical results have demonstrated that MarA is able to bind Prob, 
although no in vivo data has suggested the relevance of this interaction 
(Schneiders and Levy, 2006, McMurry and Levy, 2010). Here we show that 
under salicylate inducing conditions, MarA is capable of mildly repressing Prob 
activity, although we do note these effects are minor. We likewise observe a 
decrease in Prob activity via SoxS expression under paraquat exposure, 
consistent with the results of Michán and coworkers (Michan et al., 2002). Taken 
together, these results indicate that under chemical induction SoxS remains the 
only significant repressor of Prob activity. 
 
Autoregulation is a feature of PmarR and PsoxS but not Prob regulation. Based 
on the model proposed in Figure 3.1B, all three of the associated PmarR, PsoxS, 
and Prob promoters are subject to autoregulation. To determine the magnitude of 
these effects we created genetic backgrounds lacking each of the potential 
cross-regulatory systems, and measured the effects of transcription in the 
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presence and absence of the potential autoregulator. This approach eliminates 
any potential changes in transcriptional activity mediated by indirect activation or 
repression by the other regulatory systems. 
 In the case of PmarR, we observed MarA-dependent positive autoregulation 
(Figure 3.3A) consistent with current regulatory models (Martin et al., 1996, Ruiz 
and Levy, 2010). However, we are here able to demonstrate that loss of MarA 
alone is sufficient to cause a decrease (2.7-fold) in PmarR activity during salicylate 
exposure. Previously, Martin and coworkers arrived at this conclusion by 
monitoring PmarR transcription in a genetic background lacking the entire marRAB 
locus when MarA was overexpressed (Martin et al., 1996). In addition, PmarR 
promoter mutants, with deleted MarA binding sites, were generated and shown to 
be insensitive to MarA overexpression. They also demonstrated MarA can bind 
and activate PmarR in vitro.  Based on these lines of evidence it was concluded 
that MarA is a positive autoregulator of PmarR. These data, however, were 
interpreted when the exact nature of MarA, SoxS, and Rob binding and cross-
activation were not entirely clear. Particularly, the in vivo data were obtained in 
genetic backgrounds containing functional Rob (Martin et al., 1996). Our results, 
though complementary, provide clear, genetic evidence of MarA autoregulation in 
the absence of Rob and SoxS. 
 Consistent with our proposed model, we observed SoxS autorepression, 
though these effects appear to be minor (Figure 3.3B). We do not that our 
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minimal growth medium differs from those used in previous studies that 
employed a rich growth medium. The effects of growth medium on mar/sox/rob 
activation have been noted, and we have observed greater autorepressive 
effects in rich medium consistent with Nunoshiba and coworkers (Bailey et al., 
2006, Nunoshiba et al., 1993b)(Data not shown). Finally, we found that Rob, 
despite the model prediction, was unable to autoregulate its own expression in 
the presence or absence of the inducer decanoate. From these results, we 
conclude that while MarA and SoxS exhibit positive and negative transcriptional 
autoregulation, respectively, Rob does not. 
 
Optimal downstream response requires an intact mar/sox/rob network. We 
next wanted to determine the contribution of each system in activating 
downstream genetic targets of the mar/sox/rob regulon under conditions of 
salicylate, paraquat, and decanoate exposure. To determine the magnitude of 
these interactions, we monitored gene expression from transcriptional fusions to 
inaA (a putative kinase) and micF (the small RNA regulator of ompF mRNA 
translation). Both of these genes are well-characterized members of the 
mar/sox/rob regulon and have been observed to be bound by MarA, SoxS and 
Rob (Ariza et al., 1995, Jair et al., 1996b, Jair et al., 1995, Li and Demple, 1994, 
Rosner and Slonczewski, 1994). We found that while each system is capable of 
exacting a downstream response in the presence of a canonical inducer, it is only 
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in presence of all three systems that optimal levels of activation are achieved 
(Figure 3.4). As other reports have demonstrated the requirement of marRAB, 
soxRS, or rob for optimal resistance to antimicrobial compounds (Duo et al., 
2008, Warner and Levy, 2010, Cohen et al., 1993a, Cohen et al., 1993b, Hachler 
et al., 1991), we speculate that this loss of maximal activation is the result of 
disrupted cross-regulatory interactions. The net result being that the systems are 
unable to coordinate a response of appropriate magnitude. 
 
Rob responds to salicylate by an indirect mechanism. Although several 
compounds such as decanoate, dipyridyl and deoxycholate have been observed 
to bind and activate Rob, recent results have suggested that Rob is subject to 
activation by salicylate (Rosner and Martin, 2009, Rosenberg et al., 2003, 
Rosner et al., 2002). We found that while MarA and SoxS activated PinaA and 
PmicF in response to salicylate and paraquat, respectively, Rob alone was capable 
of activating these promoters in the presence of both salicylate and decanoate 
(Figure 3.4).  
 We next sought to determine if the interaction between Rob and salicylate 
is due to direct binding of salicylate to Rob. Previous results have shown that the 
C-terminal domain of Rob is able to bind dipyridyl and deoxycholate (Rosenberg 
et al., 2003, Rosner et al., 2002). To determine whether salicylate is bound by 
Rob, we employed isothermal titration calorimetry (ITC) using purified Rob 
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protein titrated with a salicylate solution. Our results indicate that no significant 
changes in free energy were detected during the titration experiment indicated 
that binding between Rob and salicylate did not occur (Figure 3.5). We therefore 
conclude that Rob is activated by salicylate via an indirect mechanism in vivo. 
 
cAMP receptor protein (CRP) activates PmarR through direct binding. Unlike 
the Prob and PsoxS promoters, PmarR is known to be regulated by global 
transcription factors. In particular, cAMP receptor protein (CRP) has been 
implicated as an activator of PmarR activation. Though two independent studies 
have observed decreased PmarR activity in crp null mutants, no evidence has 
been presented to show whether the interaction with CRP is direct (Ruiz and 
Levy, 2010, Zheng et al., 2004). Likewise, these results were obtained in the 
presence of intact soxRS and rob systems.  
To explore the role of CRP as an activator, we first tested the effects of 
CRP in a strain lacking marRAB, soxRS, and rob to ascertain whether CRP 
activates PmarR directly or whether CRP-dependent activation requires SoxS or 
Rob. In the absence of marRAB, soxRS, and rob we observed that transcription 
of PmarR is significantly down-regulated (Figure 3.6A). Though these results do 
not conclusively demonstrate CRP as a direct activator, they do demonstrate that 
the CRP-dependent effects observed previously are independent of SoxS and 
Rob. 
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We next wanted to test whether CRP interacts with the PmarR promoter 
region directly. To determine if CRP binds the PmarR promoter, we employed an 
electromobility shift assay using purified CRP and a 150 bp region of the PmarR 
promoter. Purification of CRP was performed using a 6xHN-CRP fusion protein. 
We found that this construct was able to fully complement the wild-type levels of 
PmarR transcription (Figure 3.6B) in vivo. As an in vitro positive control we 
observed that 6xHN-CRP was capable of binding to a 186 bp region of the PlacZYA 
promoter (Figure 3.6C). Performing a similar experiment with PmarR we observed 
that 6xHN-CRP was able to bind to PmarR (Figure 3.6C). Additionally, this 
interaction is specific as the introduction of a strong, non-labeled competitor 
resulted in decreased amounts of shifted DNA. We therefore concluded from 
these results that CRP is a direct activator of the PmarR promoter.  
 
CRP is not the mar-independent activator of the PmarR promoter. A recurring 
observation regarding the regulation of PmarR has been the existence of a 
mar/sox/rob-independent mechanism for transcriptional activation in the 
presence of inducing compounds such as salicylate (Cohen et al., 1993b, Martin 
and Rosner, 1997). Extensive transversion analysis of the PmarR promoter region 
has also demonstrated that the PmarR region containing the CRP binding site 
proposed by Zhang and coworkers (Figure 3.6D) is not involved in the mar-
independent activation mechanism (Martin and Rosner, 1997). Surprisingly, this 
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analysis did not capture the effects we observe in the absence of CRP (Figure 
3.6A). We therefore wanted to investigate the possibility of CRP as the mar-
independent mechanism of PmarR activation. 
As demonstrated in Figure 3.6A, we found that exposure of cells lacking 
marRAB, soxRS, and rob to salicylate results in persistent activation of PmarR, 
despite the primary activating components MarA, SoxS, and Rob not being 
present. Furthermore, we still observed activation in the absence of CRP. These 
results concur with those of Martin and Rosner who determined that, in addition 
to MarA, SoxS and Rob, both Fis and EmrR (a MarR-family repressor capable of 
complementing MarR at high copy) do not contribute to the mar-independent 
phenotype (Martin and Rosner, 1997). Taken together, we extend this list of 
regulators not contributing to the mar-independent activation pathway to include 
CRP. 
 
RpoS is not involved in PmarR activation. The transversion analysis of PmarR 
performed by Martin and Rosner also indicated that the only region specifically 
required for mar/sox/rob-independent activation was the RNA polymerase 
binding sites (Martin and Rosner, 1997). These data strongly suggest that 
components of RNA polymerase may be the unknown regulatory components. 
Microarray analysis of cells exposed to salicylate during log-phase growth also 
indicated that a number of genes under the regulation of RpoS (an alternate RNA 
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polyermase sigma factor) were up-regulated (Pomposiello et al., 2001). Based on 
this evidence, we looked to examine the role of the general stress response 
sigma factor, RpoS, in activating the PmarR promoter. 
 Sigma factors are components of bacterial RNA polymerase involved in 
promoter recognition and binding. Among the seven sigma factors in E. coli, 
RpoS is involved in general stress responses and the transition to the stationary 
phase of growth (Klauck et al., 2007). To date, no study has conclusively shown 
the presence of alternate sigma factor binding sites in the PmarR promoter. 
Likewise, the marRAB transcript has been determined to only possess a single 
start site when PmarR is activated by salicylate. However, RpoS recognizes many 
promoter regions in common with the vegetative growth sigma factor (RpoD) 
leading us to select RpoS as a possible candidate for a stress response sigma 
factor. 
 To test whether RpoS is involved in PmarR activation we constructed a 
mutant lacking rpoS in an otherwise wild-type genetic background. We then 
tested PmarR promoter activity in these genetic backgrounds in the presence and 
absence of salicylate (Figure 3.7). Our results clearly demonstrate that RpoS 
has no apparent role in modulating the transcriptional activity of PmarR under the 
conditions we tested. Further, we examined the possibility of RpoS affecting the 
activation of a downstream regulon promoter PinaA during salicylate exposure. We 
also found RpoS does not affect downstream activation. 
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3.3 Discussion 
 In this chapter, we have investigated the magnitude of interconnectivity in the 
mar/sox/rob regulatory network. Utilizing a genetic approach we have 
systematically shown that a fully integrated network, while possible, is not 
realized under physiological conditions. Consistent with existing models, we have 
reaffirmed that the interactions of SoxS and Rob with the PmarR promoter are the 
most significant (Miller et al., 1994, Martin and Rosner, 1997, White, 2005). 
Likewise, SoxS is capable of repressing rob gene expression by repressing the 
Prob promoter (Michan et al., 2002). Based on our results, we propose a model 
where MarA, SoxS, and Rob form a complex feed-forward regulatory network 
(Figure 3.8) that is highly conditional on the composition of the surrounding 
chemical environment. Namely, the regulatory network is capable of adopting 
network topologies based on the induction of one or more of the marRAB, 
soxRS, and rob systems. Finally, we have shown that marRAB gene expression 
is positively regulated by CRP through direct interaction with the PmarR promoter. 
 An interpretation of this model would suggest that depending on the 
chemical environment, the mar/sox/rob regulon will adopt differing downstream 
expression profiles in addition to altered response dynamics. Based on the 
regulatory architecture of positive and negative genetic interactions, feed-forward 
loops have been observed to confer networks different regulatory properties 
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(Alon, 2007, Shen-Orr et al., 2002). Therefore, we hypothesize that differing 
chemical environments capable of inducing two or more of the systems will 
possess different response profiles than one system alone. We draw support 
from this idea from the interaction between Rob and the marRAB system, both 
inducible by salicylate. Our results show that although Rob does not appear to 
respond directly to salicylate, it is through the coordinated action of the Rob and 
marRAB response to salicylate that optimal downstream activation is achieved.  
 Adding to the complex nature of the mar/sox/rob network is the capacity 
for marRAB gene expression to be influenced by global regulators such as Fis 
and CRP. We have demonstrated here that the interaction between CRP and the 
PmarR promoter is direct, and does not require Rob or SoxS. Based on this 
finding, we speculate the the marRAB system serves as a regulatory link for 
nutritional information to be fed into the mar/sox/rob regulon to produce an 
appropriate downstream response depending on cellular growth conditions. Ruiz 
and coworkers have recently demonstrated that loss of either CRP or adenylate 
cyclase (CyaA) both confer a similar downregulated phenotype in marRAB gene 
expression and that addition of cAMP to the growth media can complement the 
CyaA- phenotype (Ruiz and Levy, 2010). Our results, however, show that loss of 
CRP activity also results in reduced marRAB gene expression even in CRP 
inactivating growth conditions. This implies that, though CRP interacts with PmarR 
directly, there may be additional regulatory elements that feed into the PmarR 
promoter. Further analysis of marRAB promoter regulation will continue to 
68 
 
increase the repertoire of transcription factors converging to modulate PmarR 
activity. 
 In light of the recent findings of Ruiz and coworkers, it is clear that the 
marRAB gene expression is influenced by a large number of global factors, 
among these is CRP (Ruiz and Levy, 2010). Moreover, the PmarR promoter is the 
only of the mar/sox/rob regulatory promoters shown to be subject to global 
regulation. Therefore, an intriguing hypothesis might be that while Rob and 
soxRS respond to specific chemical signals, the marRAB system simultaneously 
integrates chemical information via MarR derepression, Rob activation, and SoxS 
expression and global regulatory information via CRP and Fis. An outcome of 
this scheme is that the feed-forward loops generated by the mar/sox/rob 
regulatory network would differentially activate and repress the large, overlapping 
regulon depending on the chemical environment and nutritional state of the cell. 
This therefore underpins the importance of understanding the regulation of 
marRAB gene expression and the role the integrated mar/sox/rob network plays 
in mediating resistance to multiple families of antibiotics when induced. 
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3.4 Figures 
 
 
 
 
 
 
Figure 3.1. The regulatory network formed by MarA, SoxS, and Rob.  A.) 
Determination of MarA, SoxS, and Rob dependent regulatory interactions 
between the marRAB, soxRS, and rob systems via complementation and 
monitoring transcriptional activity in a strain lacking all regulatory components 
except for a constitutively active allele of soxR (ΔmarRAB Δrob ΔsoxS soxR105). 
Strains used were LC760, LC761, LC762, and LC763. Cells were transformed 
with plasmids containing marA, soxS, or rob inserted into the arabinose-inducible 
pBAD30 expression vector. Transcriptional activity of PmarR, PsoxS, and Prob were 
monitored by single-copy transcriptional fusions to yfp(venus) inserted at the 
coliphage λ attachment site. Cells were grown overnight in LB and subcultured 
1:200 in fresh LB supplemented with 10 mM arabinose. Following 4 hrs of growth 
measurements of cellular fluorescence and optical density were made. 
Measurements were normalized to the empty plasmid control for each of the 
indicated transcriptional fusions B.) A depiction of the interconnected model as 
inferred from transcriptional response of PmarRAB, PsoxS,  and Prob. 
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Figure 3.2. The effects of regulatory cross-
talk between the marRAB, soxRS, and rob 
networks. A.) Activity of the PmarR promoter by 
SoxS and Rob (LC665, LC670, LC668, 
LC671) B.) Activity of the PsoxS promoter by 
MarA and Rob (LC795, LC951, LC963, 
LC761) C.) Activity of the Prob promoter by 
MarA and SoxS (LC681, LC683, LC684, 
LC685). All three regulators are expressed at 
their native locus. Cells were grown overnight 
and subcultured 1:200 in MOPS buffered 
minimal media (20 mM glucose, 0.2% 
casamino acids, pH=7.2) and grown to an 
OD=0.5. At this time, canonical inducers 
salicylate, paraquat (PQ), or decanoate were 
added to final concentrations of 5 mM, 50 µM, 
and 5 mM, respectively. Following induction, 
cultures were grown for additional 1 hr. 
Fluorescence and optical density 
measurements were made using 250 µl 
aliquots of culture in a Tecan Safire2 
microplate reader. 
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Figure 3.3. Determining the magnitude of autoregulation in the mar/sox/rob 
regulatory circuit. A.) Activity of the PmarR promoter in marA
+ (LC467) and ΔmarA 
(LC487) backgrounds (both ΔsoxS Δrob) during salicylate exposure. B.) Activity 
of the PsoxS promoter in soxS
+ (LC484) and ΔsoxS (LC488) genetic backgrounds 
(both ΔmarA Δrob) during paraquat exposure. C.) Activity of the Prob promoter in 
rob+ (LC481) and Δrob (LC489) backgrounds during decanoate exposure (both 
ΔsoxS Δrob). Cells were grown overnight and subcultured 1:200 in MOPS 
buffered minimal media (20 mM glucose, 0.2% casamino acids, pH=7.2) and 
grown to an OD=0.5. At this time, canonical inducers salicylate, paraquat (PQ), 
or decanoate were added to final concentrations of 5 mM, 50 µM, and 5 mM, 
respectively. Following induction, cultures were grown for additional 1 hr. 
Fluorescence and optical density measurements were made using 250 µl 
aliquots of culture in a Tecan Safire2 microplate reader. 
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Figure 3.4. The individual contribution of MarA, SoxS and Rob, under native 
regulation, towards activating two downstream target promoters of the 
mar/sox/rob regulon. A.) Changes in PinaA activation (LC434, LC690, LC691, 
LC689, LC692) B. Changes in PmicF activation (LC439, LC697, LC698, LC696, 
LC699). Cells were grown overnight and subcultured 1:200 in MOPS buffered 
minimal media (20 mM glucose, 0.2% casamino acids, pH=7.2) and grown to an 
OD=0.5. At this time, canonical inducers salicylate, paraquat (PQ), or decanoate 
were added to final concentrations of 5 mM, 50 µM, and 5 mM, respectively. 
Following induction, cultures were grown for additional 1 hr. Fluorescence and 
optical density measurements were made using 250 µl aliquots of culture in a 
Tecan Safire2 microplate reader. 
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Figure 3.5. Rob does not directly 
bind salicylate. Measurements were made using a VP-ITC (MicroCal) calorimeter 
with purified Rob (10 µM) and salicylate (10 mM). Rob was extensively dialyzed 
against tris-buffered saline (50 mM Tris-HCl, 500 mM NaCl, pH=8.0) and protein 
concentration was determined by the BCA assay method (Pierce). Sodium 
salicylate solutions were prepared to 10 mM in tris-buffered saline and the pH 
was brought to 8.0 by titration with NaOH freshly prior to experiments. Both Rob 
and salicylate solutions were degassed for at least 15 minutes at room 
temperature. ITC runs were conducted by titrating 28 x 10 µl salicylate aliquots 
against the Rob protein sample with constant stirring at 300 rpm and a 
temperature of 25oC. Data were collected and analyzed using the Origin-based 
MicroCal software suite. 
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Figure 3.6. Catabolite repressor protein (CRP) activates marRAB transcription 
by binding directly to PmarR. A.) Affects of CRP on the background levels of PmarR 
activity in LC671 (crp+) and LC1160 (Δcrp). Cells were grown in MOPS buffered 
minimal media (20 mM glucose, 0.2% casamino acids, pH=7.2) B.) 
Complementation of CRP-dependent activation by 6xHN-CRP expressed from 
pPROTet.E133 (Vector) and pPROTet.E-crp-1 (pCRP) in LC671 (crp+) and 
LC1160 (Δcrp). Cells were grown in MOPS buffered minimal media (20 mM 
glucose, 0.2% casamino acids, pH=7.2) C. Electrophoretic mobility shift assays 
of 6xHN-CRP with indicated DNA regions. All binding reactions contained 0.2 
mM cyclic-AMP, 10 ng P32-labeled DNA, and 6xHN-CRP (16, 32, 63, 125, 250, 
500 ng). Reactions were displayed on a 5% 0.5XTBE polyacrylamide gel 
containing 0.2 mM cyclic-AMP, run at 150V for 40 minutes at 4oC. D.) The 
regulatory binding sites present in PmarR. The CRP site proposed by Zheng and 
coworkers (Zheng et al., 2004) is labeled in bold print. 
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Figure 3.7. RpoS does not contribute to the activation of PmarR. Activity of 
promoters in the presence and absence of salicylate. A.) Activity of the PmarR 
promoter in a rpoS+ (LC433) and ΔrpoS (LC1031) background. B.)Activity of the 
PinaA downstream promoter in a rpoS
+ (LC434) and ΔrpoS (LC1032) background. 
Cells were grown overnight and subcultured 1:200 in MOPS buffered minimal 
media (20 mM glucose, 0.2% casamino acids, pH=7.2) and grown to an OD=0.5. 
At this time, salicylate was added to final concentrations of 5 mM. Following 
induction, cultures were grown for additional 1 hr. Fluorescence and optical 
density measurements were made using 250 µl aliquots of culture in a Tecan 
Safire2 microplate reader. 
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Figure 3.8. A reduced network model of the mar/sox/rob network including 
known global regulators. Dashed lines indicate interactions deemed weak based 
on the results of this work. 
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Chapter 4: MarA serves as a conditional autorepressor and set-
point controller of its own expression  
 
4.1  Introduction 
In the preceding chapter, we have systematically defined the interconnectivity 
existing in the mar/sox/rob regulatory circuits. Of these interactions, we wished to 
more thoroughly investigate the interactions between Rob and the marRAB 
systems. Particularly, both systems are capable of responding to a common 
inducer salicylate. For the marRAB gene circuit, this response is mediated 
through the binding of salicylate to the autorepressor MarR, resulting in 
depression of the PmarR promoter and expression of MarA (Martin and Rosner, 
1995, Martin and Rosner, 2004, Cohen et al., 1993b). In the case of Rob, 
however, it is been observed in this work that it does not interact directly with 
salicylate. We currently hypothesize that Rob is activated by salicylate through a 
yet unknown, indirect mechanism. Additionally, the marRAB circuit possesses a 
unique regulatory arrangement. The marRAB operon contains both positive and 
negative autoregulators of PmarR promoter activation.   
 Based on the proposed regulatory model in Chapter 3 (Figure 3.8), Rob 
and MarA form a coherent feedforward regulatory loop. A number of 
experimental and theoretical studies have ascribed specific dynamic properties to 
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coherent feedforward regulatory networks (Shen-Orr et al., 2002, Alon, 2007). 
Intrigued by the possibility of an a priori predictive model for mar/sox/rob regulon 
activation, we wanted to fully characterize the transcriptional response dynamics 
associated with the Rob-MarA feedfoward regulatory loop. 
 In this chapter, we illustrate how MarA positive feedback on the PmaR 
promoter actually serves as a negative feedback, set-point mechanism in the 
presence of Rob. We propose a model to explain this behavior where MarA is 
capable of outcompeting Rob for binding at the PmarR promoter, but serves as a 
weaker activator. The net result being that MarA serves to dampen the positive 
inputs from Rob and additional regulators such as CRP. This in turn produces a 
fine-tuned response.  
 
4.2 Results 
MarA imposes conditional negative feedback on its own expression. A 
notable feature of the marRAB operon is the encoded capacity for MarA-
dependent autoactivation (Martin et al., 1996, Cohen et al., 1993a). Previous 
studies by Martin and coworkers have demonstrated through complementation of 
MarA, and mutations of the MarA binding box in the PmarR promoter, that MarA is 
capable of positively autoregulating its own expression (Martin et al., 1996). This 
analysis, as the authors note, was performed in the presence of Rob, although 
they state Rob was found to not significantly affect their conclusions. Likewise, 
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loss of marA alone was not explored. However, as Rob is a prominent activator 
of the PmarR promoter, we desired to understand the interplay between MarA and 
Rob in activating PmarR.  
To quantify the contribution of MarA-mediated autoactivation under 
physiological conditions, we introduced an in-frame deletion of marA into an 
otherwise wild-type background and in the absence of rob. The effects of these 
deletions on gene activation were then quantified using transcriptional fusions of 
PmarR and Prob to a fast-folding YFP variant, Venus (Nagai et al., 2002). 
Depression of PmarR and activation of Rob was mediated with two well-
characterized inducers salicylate and decanoate, respectively (Cohen et al., 
1993b, Rosenberg et al., 2003, Griffith et al., 2009, Martin and Rosner, 1995). 
Despite the apparent autoactivating role of MarA, we observed no loss in 
PmarR promoter activity in the absence of marA (Figure 4.1A) when activated with 
salicylate. Interestingly, in the absence of Rob, we found only then did the 
deletion of marA result in decreased levels of PmarR activation. An interpretation 
of these results may be that the binding of Rob at the PmarR promoter may block 
the binding of MarA and thereby inhibiting autoactivation. Alternatively, as MarA 
has been implicated in the transcriptional repression of rob transcription, 
increased levels of rob gene expression in the absence of MarA may account for 
the epistatic effects of Rob on MarA autoregulation (Schneiders and Levy, 2006, 
McMurry and Levy, 2010). Although we did observe minor increases in Prob 
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transcription during salicylate induction (Figure 4.1B) in strains lacking marA, we 
suspect based on magnitude of these changes that overall changes in Rob 
abundance under these conditions remains relatively unchanged. 
 We next explored the dynamic consequences of PmarR activation during 
salicylate induction. Most strinkingly, we observed that in a marA mutant, levels 
of PmarR activation were nearly 35% higher than wild type levels after 2.5 hours of 
induction (9061±182 RFU/OD vs. 6676±350 RFU/OD, Figure 4.2A). Again, in 
the absence of Rob, we found that PmarR activity was decreased. Loss of both 
marA and rob ultimately resulted in further inactivation of PmarR. We do note the 
residual activity of PmarR in the absence of known activators and is a 
phenomenon noted in prior studies (Martin and Rosner, 1997). Specifically, 
treatment of cells with salicylate is known to activate PmarR transcription in the 
absence of all known regulators. Although we have shown cAMP receptor protein 
(CRP) is a component of this residual activity, additional transcription factors are 
believed to modulate PmarR activity (Figure 3.6)(Ruiz and Levy, 2010) 
 Previous genetic and biochemical analysis has shown that the 
homologous regulators MarA and Rob each serve as activators of the PmarR 
promoter (Martin and Rosner, 1997). Their role as activators can be 
demonstrated in the activation of the downstream PinaA promoter (Figure 4.2B). 
Like many of the promoter activated by MarA, SoxS, and Rob, the sites in PinaA 
are overlapping and are in the forward, class II arrangement (Martin et al., 1999). 
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Similar arrangements are found in many downstream promoters such as PmicF. At 
the PmarR promoter, however, it appears a different mechanism may be at work to 
produce the increase in activation seen in the absence of marA. Based on the 
structure of the PmarR promoter (Figure 3.6D), particularly the common binding 
site for MarA and Rob, we hypothesize that MarA and Rob compete for this site 
during salicylate induction. Likewise, the overlapping mar/sox/rob sites in PmarR 
are in the reverse, class I arrangement suggesting a different binding mode and 
contacting of RNA polymerase (Martin et al., 1999, Schneiders and Levy, 2006, 
Schneiders et al., 2004, Martin et al., 2002). Following this logic, we propose a 
competitive promoter binding and activation mechanism. To attain the observed 
results in this scenario, given our observations, would be that MarA is able to out-
compete Rob at the PmarR promoter but is ultimately a weaker activator in 
comparison to Rob. The net result being MarA, though an activator, is exerting 
conditional negative feedback on its own expression. 
 We draw support for this hypothesis from a number of observations. 
Recent estimates of MarA concentrations place MarA at approximately 9,000 
molecules/cell (Martin et al., 2008). Given the levels of Rob range between 5,000 
to 10,000 molecules/cell (Skarstad et al., 1993), and Rob is not significantly 
activated by salicylate (Figure 4.2D), we speculate that the concentration of 
MarA is higher than free Rob under salicylate induction. Likewise, MarA and Rob 
have relatively similar affinities for the PmarR promoter (Kwon et al., 2000). Taken 
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together, MarA is presumably at higher abundance and therefore able to 
outcompete Rob for binding. 
 Modeling results from Wall and coworkers have recently shown that 
binding of MarA to the PmarR promoter does not increase occupancy of RNA 
polymerase (Wall et al., 2009). Moreover, MarA is able to bind to RNA 
polymerase very tightly in solution. In competitive binding experiments between 
MarA, Rob and RNA polymerase, nearly 40-fold higher concentrations of Rob 
were required to compete with MarA binding to RNA polymerase (Martin et al., 
2002). However, this result is complicated by the fact that the in vitro behavior of 
Rob does not accurately reflect the in vivo, physiological behavior of Rob 
(Rosner et al., 2002). Though the exact nature of the competitive interaction is 
not entirely clear, based on the above evidence, our proposed mechanism 
explains our data and concurs with prior investigations. 
 Finally, we explored the range of salicylate dosages where we observed 
the increase in PmarR  activation in the absence of marA (Figure 4.2C). These 
results indicate that at >1 mM salicylate PmarR has elevated levels of activation in 
a marA mutant. Based on this observation we suggest that the effects observed 
are independent of MarR as it has been shown that extracellular concentrations 
of 5 mM are required for MarR to be complete unbound from PmarR (Martin and 
Rosner, 1995, Alekshun and Levy, 1999a, Martin and Rosner, 2004). All 
together, we conclude that MarA outcompetes Rob at the PmarR promoter under 
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salicyate induction, but behaves as a weaker activator. The net result is that 
MarA conditionally autorepresses its own activation. 
 
MarA and Rob bind PmarR with similar affinity in vitro. Reports of MarA and 
Rob affinity for the PmarR promoter have varied. Kwon and coworkers previously 
reported a nearly 10 fold greater affinity for Rob to the mar/sox/rob box of PmarR 
compared to MarA (Kwon et al., 2000). Conversely, Martin and coworkers have 
reported binding coefficients of MarA and Rob to the entire PmarR promoter to be 
much closer in magnitude with Rob binding only marginally stronger. To 
discriminate between these two results we sought to qualitatively determine if 
binding of MarA versus Rob was significantly different under equimolar 
conditions. 
 Using purified MarA and Rob protein, we performed electromobility shift 
assays to qualitatively assess differences in DNA binding affinity to the PmarR 
promoter (Figure4.3) . We found that despite reports of strongly disparate 
binding affinities, that MarA and Rob appear to binding with similar affinities. We 
therefore, based on our qualitative results, support the findings of Martin and 
coworkers. MarA and Rob bind PmarR with similar affinity. 
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Maximal rate and amplitude of downstream activation requires both MarA 
and Rob. In addition to affecting the amplitude of genetic responses, feedforward 
loops have also been observed to alter the rate and timing of genetic responses 
(Alon, 2007, Saini et al., 2010). As both PmarR and Rob are activated by salicyate, 
and Rob activates PmarR, forming a coherent feedfoward loop to activate 
downstream targets, we wished to explore the impact of MarA and Rob working 
together to modulate downstream activation. To directly test the effects of MarA 
and Rob, we monitored gene expression from the PinaA promoter, a well 
characterized member of the mar/sox/rob regulon that responds to both MarA 
and Rob (Figure 4.1C). 
The downstream response of PinaA, consistent with our current regulatory 
model (Figure 3.8), shows severe attenuation of PinaA promoter activity in 
mutants lacking marA under salicylate induction (Figure 4.1C). Similarly, a rob 
mutation is manifested as the loss of PinaA activity during salicylate and 
decanoate induction. This is the consequence of PmarR promoter activity 
decreasing in the absence of Rob as well as Rob being activated by both 
inducing compounds. The net result being that in a rob mutant the Rob-MarA 
feedforward loop is inactivated resulting in a loss in amplitude of downstream 
regulon activation. 
 While both the marA and rob mutants display losses in amplitude of 
response, their relative effects on response dynamics differ. In the case of a 
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marA mutant, we observed that activation was delayed and occurred at a much 
slower rate (Figure 4.2B). Conversely, we found that the rob mutant exhibited 
slower rates of gene activation compared to wild type, but faster than the marA 
mutant. From these findings, we conclude that the Rob-MarA feedfoward loop 
works to increase the rate and amplitude of the mar/sox/rob regulon activation 
during salicylate exposure.  
 
Activation of PmarR transcription is a graded response. An interesting 
response characteristic in genetic regulatory circuits containing positive feedback 
elements is the emergence of multistability (Guido et al., 2006, Isaacs et al., 
2003, Becskei et al., 2001, Maeda and Sano, 2006, Ozbudak et al., 2004, 
Mitrophanov and Groisman, 2008). If positive feedback is sufficiently strong and 
cooperative, genetic regulatory networks have been observed to exhibit switch-
like activation, wherein a population heterogeneously transitions from a singular 
off-state to on-state. Conversely, the presence of weak positive feedback or 
negative feedback has been shown to produce graded or rheostat-like where 
populations homogenously migrate from an off to on state continuously. An 
additional physiological aspect of positive feedback is the relative stability of the 
regulatory elements involved. If the associated regulators are subject to rapid 
degradation, then it believed the contributions of their positive effects are 
minimized, resulting in a homogeneous response. As the marRAB gene circuit 
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contains a positive feedback element, we wished to explore the possibility that 
PmarR may act as a dynamic switch as has been observed for other systems 
(Saini et al., 2010).  
To determine which of these cases occurs for PmarR activation, we 
measured fluorescence in single cells using flow cytometry. Populations of 
induced cells were fixed at 15 minute intervals for one hour of sampling time to 
monitor the kinetic behavior of the off to on transition in salicylate induced cells. 
Our results clearly indicate that the PmarR has rheostat-like activation profile 
indicating that MarA-positive feedback is not sufficiently strong enough to induce 
a bistable switch (Figure 4.4). Additionally, MarA is known to be rapidly 
degraded by the ATP-dependent Lon protease (Griffith et al., 2004). Although 
this factor was not controlled for in our experiments, we believe this is a 
contributing factor to the homogeneous activation phenotype although no 
evidence has been suggested that PmarR response dynamics are changed in the 
absence of Lon protease. Moreover, effects of lon mutations are pleiotropic 
rendering correlation of Lon-dependent effects difficult in vivo. These results 
confirm the assertion of Martin and coworkers who have recently speculated that 
the marRAB circuit would possess a graded response (Martin et al., 2008). 
 
The effects of combined marRAB and Rob activation result in additive 
downstream responses. Several promoters of the mar/sox/rob regulon have 
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been shown to be activated in proportion to the concentration of MarA present 
(Martin et al., 2008). Likewise, many promoters of the mar/sox/rob regulon, 
including PinaA, have been observed to not reach saturated levels of activation 
(Martin et al., 2008). This unusual property suggests the potential for synergistic 
response. As the Rob-MarA feedfoward loop is capable of responding to multiple 
chemical inputs, we wished to explore the possibility of synergistic regulon 
activation in the presence of multiple inducers.  
To test the possibility of synergistic activation of the Rob-MarA feedfoward 
loop, we measured promoter activities of the PmarR and PinaA promoter after co-
induction with variable concentrations of salicylate and decanoate. Based on our 
observations, found that synergistic activation was not observed (Figure 4.5). 
Specifically, nothing beyond additive levels of activation of PinaA were seen. An 
interpretation of these results would suggest that while Rob-MarA feedforward 
loop is important for a strong, timely transcriptional response from the 
mar/sox/rob regulon, it is not capable of producing synergistic transcriptional 
responses. 
 
4.3 Discussion 
In this chapter, we have explored the role of MarA-dependent autoregulation of 
the PmarR promoter. Contrary to the current model of PmarR regulation where MarA 
is an autoactivator, our results indicate that MarA behaves as a conditional 
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autorepressor of marRAB activation (Martin et al., 1996). Additionally, the 
conditional autorepressive action of MarA is only observed in the presence of 
Rob. Based on these findings, we propose a competitive binding and activation 
model to account for the observed transcriptional phenotype of PmarR (Figure 
4.6). 
 To adequately account for the behavior seen for the levels of PmarR 
activation in a marA mutant, we hypothesize that MarA is capable of 
outcompeting Rob for binding at the PmarR promoter. Likewise, of the two 
regulators, Rob is a stronger activator of PmarR promoter activity. In support of this 
view, we have shown that MarA is capable of competing with Rob at the PmarR 
promoter in vitro (Figure 4.3). Similarly, our previous results have indicated Rob 
is a stronger activator of PmarR activation than MarA (Chapter 3).  
  A simple outcome of this proposed model is that MarA conditional 
autorepression works as a set-point mechanism to ensure appropriate amounts 
of MarA are produced. Most regulators known to interact with the PmarR promoter 
serve as activators (Fis, CRP, Rob, and SoxS). The result is that, during PmarR 
activation, an array of environmental inputs is capable of increasing MarA 
expression (Figure 4.7). As a result, under certain conditions (namely nutrient 
limited antibiotic stress), MarA may be expressed at very high levels. Several 
reports have indicated that overexpression of MarA is detrimental to cellular 
viability (Griffith et al., 2004). Therefore, we suggest that the autorepressive 
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nature of MarA at the PmarR promoter may serve to balance the net benefit of 
expressing MarA with the negative outcome of expressing MarA at too high a 
level. 
 Additionally, we have shown in this work that the coherent feedforward 
loop formed by Rob and MarA works to speed up and amplify the downstream 
transcriptional response of the mar/sox/rob regulon. We have also demonstrated 
that the Rob-MarA feedforward loop acts additively in activating downstream 
targets. As MarA is capable of autorepressing its own activation, we found this 
result in accordance with the proposed regulatory model. 
 Finally, we have demonstrated that activation of the PmarR promoter is a 
graded response. Systems which possess positive feedback often display 
bistable, switch-like reponses (Mitrophanov and Groisman, 2008). As the 
marRAB circuit contains a positive feedback element, we wished to determine 
whether a heterogeneous response from this system was possible. Based on our 
findings, we speculate that the positive feedback imposed by MarA is not 
sufficiently strong to result in swich-like activation of PmarR. Furthermore, given 
the conditional autorepressive function of MarA, we suspect that the likelihood of 
a bistable response in the marRAB circuit is unlikely. 
 Of the members of the mar/sox/rob regulatory circuits, the marRAB 
system is arguably the most complex. As it is influenced by CRP and Fis as well 
as MarA, SoxS, and Rob the marRAB acts as a regulatory hub in this network 
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integrating both local and global chemical information (Ruiz and Levy, 2010). 
Adding to the complex nature of PmarR regulation is the conditional autorepressive 
role of MarA, described in this work. Though the MarA is one of the most 
extensively characterized transcriptional regulators, the biochemical mechanism 
at work at the PmarR promoter requires further investigation. 
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4.4 Figures 
 
 
 
Figure 4.1. Expression of the A.) PmarR (LC433, 
LC475, LC483, LC492) and B.) Prob 
(LC440,LC477, LC485, LC494) C.) PinaA 
(LC434, LC478, LC486, LC495) promoters 
under salicylate and decanoate induction in the 
presence and absence of marA and rob. Cells 
were grown overnight in MOPS buffered 
minimal medium (20 mM glucose, 0.2% CAA, 
pH=7.2) and subculured 1:200 fresh medium. 
Cultures were grown to mid-logarithmic phase 
(OD=0.5) and induced with 100 µl of media 
containing concentrated inducer. Final inducer 
concentration are indicated. Induced cultures 
were propagated for an additional 1 hr prior to 
fluorescence and optical density 
measurements. 
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Figure 4.2. Kinetic and dose responses of the PmarR and downstream PinaA 
promoters in response to salicylate. A and B.) Time course gene expression as 
measured by fluorescence in the presence of 5 mM salicylate. C and D.) Dose-
dependent transcriptional response as measured by fluorescence in the 
presence of indicated salicylate concentrations. All experiments were conducted 
in MOPS buffered minimal medium (20 mM glucose, 0.2% casamino acids, 
pH=7.2). For kinetic experiments, overnight cultures were diluted 1:200 and 
grown for two hours (OD=0.15) prior to induction. Following induction, 150 µl 
culture was transferred to sterile 96-well microtiter plates and sealed with 
Breathe-Easy membranes. Plates were incubated in a Tecan Safire2 microplate 
reader at 37oC with shaking. Fluorescence and optical density measurements 
were made every 15 minutes as programmed by the instrument. Fluoresence/OD 
units are reported as x10-3. For end-point measurements, cultures were 
inoculated as for kinetic experiments, however, induction cultures were grown for 
3 hrs prior to measurement (250 µl aliquots). 
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Figure 4.3 MarA and Rob binding to the PmarR promoter region. MarA and Rob 
were supplied at increasing concentration to 2.5 ng of P32-labeled PmarR DNA 
(150 bp fragment used in Chapter 3). Concentrations of MarA and Rob were 
equimolar (13 nM, 25 nM, 50 nM, 100 nM). Binding reactions were displatyed on 
5% acrylamide gels buffered with 0.5X TBE at 150V for 45 minutes. Reactions 
were displayed on gels run simultaneously. The reaction buffer contained 1  mM 
MgCl2 in addition to the recipe provided in Materials and Methods. 
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Figure 4.4. Dynamic single-cell response of PmarR activation in the presence of 5 
mM salicylate as measured by flow-cytometry. Measurements were made from 
cells fixed every 15 minutes for 1 hour. A.) Wild-type. B.) ΔmarA C.) Δrob D.) 
ΔmarA Δrob. Cells were grown in MOPS buffered minimal media (20 mM 
glucose, 0.2% casamino acids, pH=7.2). Subculture (1:200) cells were grown to 
mid-log phase (OD=0.5) and induced with 5 mM salicylate. 
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Figure 4.5. Coinduction of cells with salicylate and decanoate. Cells were grown 
overnight in MOPS buffered minimal medium (20 mM glucose, 0.2% CAA, 
pH=7.2) and subculured 1:200 fresh medium. Cultures were grown to mid-
logarithmic phase (OD=0.5) and induced with 100 µl of media containing 
concentrated inducer. Final inducer concentration are indicated. Induced cultures 
were propagated for an additional 1 hr prior to fluorescence and optical density 
measurements. RFU refers to relative fluorescence. Units reported are x103. 
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Figure 4.6. Illustration of the competitive binding and activation model proposed 
for MarA and Rob. A is representative of MarA, R is representative of Rob. 
Relevant mutant genotypes are indicated. 
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Figure 4.7. A illustration of MarA autoregulatory set-point control. 
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Chapter 5: The role of MarA and Rob in coordinately modulating 
OmpF expression at the transcriptional and post-transcriptional 
levels 
 
5.1  Introduction 
One of the initial survival mechanisms for gram-negative bacteria during 
antibiotic exposure is the alteration of outer membrane porin composition (Pages 
et al., 2008). By modulating the ratios of these molecular pores, cells are capable 
of preventing the uptake of membrane impermeable drugs. In Escherichia coli, 
and closely related organisms, this is primarily mediated through changing the 
ratio of two major outer membrane pores OmpF and OmpC, the large and small 
porins, respectively (De la Cruz and Calva, 2010, Pages et al., 2008). 
 Both OmpF and OmpC exist as trimers of 16 stranded β-barrels forming 
two structurally similar outer membrane pores, but with differing substrate 
specificities and diffusion rates (Cowan et al., 1992, Basle et al., 2006). Of the 
two porins, OmpF allows diffusion of larger molecular species and faster rates of 
diffusion than OmpC (Cowan et al., 1992). Thus, by altering the ratio of these two 
pores in the outer membrane, gram-negative bacteria are able to exquisitely 
control the passive uptake of chemicals from the surrounding environment. 
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 Alteration of the OmpF/OmpC ratio is complexly regulated at the 
transcriptional and translational levels (De la Cruz and Calva, 2010). At the level 
of transcription, ompF and ompC gene expression is principally controlled by the 
EnvZ-OmpR two-component regulatory system (Slauch and Silhavy, 1989, 
Slauch et al., 1988). Under conditions of low osmolarity, OmpR is primarily 
unphosphorylated resulting in low concentrations of OmpR-Pi. At low 
concentrations, OmpR-Pi preferentially binds to high-affinity sites in the PompF 
promoter resulting in high levels of ompF transcription. Conversely, under 
conditions of high osmolarity, OmpR is phosphorylated by the activated EnvZ 
sensor-kinase, resulting in increased OmpR-Pi concentrations. At high OmpR-Pi 
centrations, OmpR-Pi binds to low affinity  sites in the PompF and PompC promoters, 
favoring reduced transcription of ompF and increased expression of ompC 
mRNA (Forst et al., 1989, Pratt et al., 1996, Pratt and Silhavy, 1995). 
Additionally, numerous other regulatory elements converge at the transcriptional 
level to aid in the effective switching between OmpF and OmpC expression 
depending on other environmental conditions such as temperature and the 
presence of membrane destabilizing agents . 
 In conjunction with transcriptional regulation of ompF gene expression are 
a number of small regulatory RNA (sRNA) species that have been identified to 
inhibit the translation of the ompF mRNA (De la Cruz and Calva, 2010, Vogel and 
Papenfort, 2006). These sRNA molecules, when expressed, are known to bind to 
the 5‟-untranslated region (5‟-UTR) of the ompF mRNAs blocking ribosomal 
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binding to the mRNA, thereby stopping ompF translation. Chief among these is 
the MicF sRNA, the first sRNA regulator to be discovered (Mizuno et al., 1984). 
 The expression of MicF sRNA, in addition to OmpR-dependent regulation, 
is modulated by a large number of global transcription factors such as H-NS, Lrp, 
and IHF (Deighan et al., 2000, Ferrario et al., 1995, Huang et al., 1990). More 
importantly for the antibiotic resistance phenotype exhibited by E. coli, is the 
action of three homologous regulators MarA, SoxS, and Rob in upregulating 
micF gene expression (Kwon et al., 2000, Martin and Rosner, 2002, Li and 
Demple, 1994, Gillette et al., 2000). MarA, SoxS, and Rob are three homologous, 
AraC/XylS-family transcription factors that are the master regulators of the 
extensive mar/sox/rob regulon involved in intrinsic multidrug resistance in enteric 
γ-proteobacteria (Martin and Rosner, 2002). The regulation of MarA and SoxS 
expression is chiefly mediated at the level of transcription by the MarR repressor 
and SoxR redox-senor/activator, respectively (Cohen et al., 1993a, Wu and 
Weiss, 1992, Nunoshiba et al., 1992). Conversely, Rob is expressed 
constitutively and activated at the post-translational level by a „sequestration-
dispersion‟ mechanism (Griffith et al., 2009). The transition of Rob from the 
inactive to active state is thought to occur through binding of small molecules to 
its C-terminal domain (Rosenberg et al., 2003, Rosner et al., 2002, Kwon et al., 
2000). Further, these three regulators form a complex network of feed-forward 
regulatory loops to differential manage the downstream regulon (Chapters 3 and 
4). Of the regulatory loops formed, the coherent type 1 loop formed by Rob and 
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MarA is critical for the effective response of mar/sox/rob circuit to aromatic, 
lipophilic toxins such as salicylate. 
A notable anomaly of OmpF/OmpC regulation has been the decrease in 
abundance of OmpF (and correlated increase of OmpC abundance) on the loss 
of the outer membrane efflux pore TolC (Morona and Reeves, 1982). 
Understanding of this phenotype was largely ascribed to the action of MicF by 
Misra and Reeves, who observed that deletions in the micF coding region 
resulted in suppression of the TolC-dependent OmpF/OmpC phenotype (Misra 
and Reeves, 1987, Misra and Reeves, 1985). Likewise, it was shown that micF 
transcription was elevated in a tolC null mutant (Misra and Reeves, 1987, Rosner 
and Martin, 2009). Recent observations made by Rosner and Martin have also 
shown that the levels of marA and soxS expression as well as Rob activation are 
elevated approximately two-fold in tolC null mutants (Rosner and Martin, 2009). 
The increase in mar/sox/rob regulon activation has been attributed to the 
elevated, intracellular levels of intermediary metabolites that serve as 
mar/sox/rob inducers. Evidence of this effect has been recently been ascribed, in 
part, to aromatic metabolites in the production of the iron chelator enterobactin 
(Chapter 6). 
 Further connecting the mar/sox/rob regulon to control of the OmpF/OmpC 
ratio, is the observation that exposure of cells to salicylate (a well-charactized 
inducer of MarA expression) is capable of producing an OmpF/OmpC phenotype 
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similar to that of a tolC mutant. The work of Rosner and coworkers has 
previously demonstrated that salicylic acid exposure results in elevated levels of 
MicF and reduced OmpF expression and that this phenotype was at least 
partially OmpR-dependent (Rosner et al., 1991). Subsequent analysis has shown 
that MarA, SoxS, and Rob are all capable of positively regulating micF gene 
expression. However, their relative roles in reducing OmpF levels has not been 
fully explored . 
A number of outstanding questions exist regarding the previously 
mentioned results. First, how does the mar/sox/rob regulatory loop contribute to 
the OmpF/OmpC switch? Previously, Cohen and coworkers have shown that 
while constitute expression of MarA is capable of producing an OmpF- 
phenotype, a marA mutant was not sufficient to restore a OmpF+ phenotype in 
the presence of salicylate (Cohen et al., 1993b, Cohen et al., 1988). Second, 
what elements of the mar/sox/rob contribute significantly to the OmpF- phenotype 
observed in tolC mutants? Does this phenotype require the action of all three 
systems? In this chapter we address these two questions. We provide genetic 
and physiological evidence that salicylate response is through the parallel action 
of MarA and Rob. Moreover, we demonstrate that MarA and Rob affect ompF 
transcription during salicylate exposure. Finally, we show that the effects 
observed in tolC mutants are primarily due to the action of Rob through activating 
micF transcription. 
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5.2 Results 
The salicylate-induced reduction of OmpF and increase of OmpC  requires 
OmpR. Traditionally, analysis of the genetic regulation of ompF and ompC 
expression has been conducted in derivatives of E. coli K-12 strain MC4100 
(Slauch and Silhavy, 1989, Slauch et al., 1988). This strain bears the ΔlacU169 
deletion that encompasses the lacZYA operon in addition to a number of other 
genes including those of the betIBA operon (Peters et al., 2003). The betIBA 
operon encodes the genes to synthesis glycine betaine, an osmoprotectant, from 
choline (Landfald and Strom, 1986). As our experiments are conducted in 
derivatives of MG1655, which possesses an intact betIBA locus, we wished to 
first determine if the changes in OmpF/OmpC expression would be observed 
under salicylate exposure.  
 To determine the effects of salicylate on OmpF/OmpC expression, we 
harvested insoluble membrane fractions from cells grown in a rich, low osmolarity 
medium (Kawaji et al., 1979) in the presence or absence of salicylate (Figure 
5.1). We were able to observe a marked decrease in the levels of OmpF in the 
outer membrane. Likewise, we observed a moderate increase in the levels of 
OmpC. Interestingly, Rosner and coworkers observed a decrease in the levels of 
OmpC when cells were cultured in low-salt Luria-Bertrani media (Rosner et al., 
104 
 
1991). We suspect the discrepancy between these findings may be due to the 
differences in strain backgrounds and growth conditions.  
We additionally explored the effects of OmpR on regulating OmpF/OmpC 
expression under salicylate exposure (Figure 5.1). Consistent with current 
regulatory models, neither OmpF or OmpC are expressed in the absence of 
OmpR. Moreover, we observe that neither OmpF or OmpC are expressed under 
salicylate exposure. This indicates that salicylate induced OmpF reduction and 
OmpC increases require OmpR. 
 
Salicylate induced reduction of OmpF requires either Rob activation or 
MarA expression. Under conditions of salicylate exposure, we have previously 
shown that both Rob and MarA are required for an optimal downstream, genetic 
response. Further, it is through the formation of a coherent, type 1 feedforward 
regulatory loop between Rob and MarA that a strong, rapid transcriptional 
response is achieved. In short, downstream genetic targets in the mar/sox/rob 
regulon need both Rob and MarA for full activation and MarA expression strongly 
depends on Rob activation of the PmarRAB promoter. 
 Based on the results of Cohen and coworkers, salicylate induced OmpF 
reduction was not observed to be due to the action of MarA alone (Cohen et al., 
1993b). Given our current regulatory model, we hypothesized that loss of either 
MarA or Rob alone may not be sufficient to suppress MicF-dependent reductions 
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in OmpF given that both regulatory systems respond to salicylate. To explore this 
possibility, we monitored the expression from single-copy transcriptional fusions 
of ompF and micF and a translational fusion of ompF to the fast-folding YFP 
variant Venus (Nagai et al., 2002). Expression was measured in a series of 
genetic backgrounds where the marRAB, soxRS, and rob regulatory components 
of the mar/sox/rob network have been systematically deleted. As an additional 
control, we tested the expression of these fusions in a strain lacking micF. 
 The results of these experiments demonstrate that both MarA and Rob 
work in parallel to reduce OmpF expression in the presence of salicylate (Figure 
5.2 and Figure 5.3). Specifically, we observed a similar 2.5 fold decrease in 
ompF mRNA translation on the loss of either marRAB (MarA-) or rob (Rob-). 
However, no change was observed in the absence of soxRS (Figure 5.2B). This 
was also reflected in the levels of expression from the PmicF promoter where we 
found that 1.4 or 2.1 fold decreases were seen on the loss of marRAB or rob, 
respectively (Figure 5.2C). Most importantly, we discovered that in mutants 
lacking both marRAB and rob, the levels of ompF mRNA translation were 
increased >6 fold with correlated decreases in PmicF activity of >26 fold.  
We also monitored expression of these fusions in mutants lacking micF. 
Given the current regulatory model, disruptions in micF should result in 
comparable levels of ompF translation to those observed in a marRAB rob (or 
marRAB soxRS rob) double mutant. Surprisingly, we found that the marRAB rob 
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double mutant exhibited 2 fold higher levels of ompF translation than the micF 
mutant. These results demonstrate that while micF is a determinant in down-
regulating ompF translation, MarA and Rob appear to regulate ompF translation 
through a MicF-independent pathway. This conclusion is further supported by the 
phenotypic observation that OmpF levels are higher in mutants lacking marRAB 
and rob than mutants lacking micF alone (Figure 5.3). 
All together, these findings show that either expression of MarA or 
activation of Rob is sufficient to down-regulate OmpF expression under salicylate 
exposure. We propose this as an explanation for the findings of Cohen and 
coworkers (Cohen et al., 1993b). Due to the parallel nature of MarA and Rob-
dependent regulation of PmicF, loss of only one system would not significantly 
impair the reduction of OmpF. A final conclusion from these data is that although 
MicF provides a simple mechanism for OmpF reduction, it is clear that an 
additional MarA/Rob-dependent mechanism exists. Whether this is through the 
regulation of another sRNA or the indirect alteration of ompF mRNA translation is 
not clear. 
 
MarA and Rob affect levels of transcription from the PompF promoter. 
Through monitoring PompF promoter activity under salicylate exposure, we found 
that MarA and Rob additively contribute to the levels of PompF promoter activity 
(Figure 5.2A). Interestingly, the PompF expression values obtained in the marRAB 
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rob double mutant were nearly identical to those in the micF mutant. We 
speculate that levels of micF production, and thereby the levels of OmpF protein 
expressed, under salicylate exposure may indirectly feedback on the PompF 
promoter. Support for this hypothesis can be derived from the observation that 
both MarA and Rob upregulate micF gene expression and loss of both of these 
regulators results in an apparent MicF- phenotype (Figure 5.2C). Likewise, no 
evidence currently exists that MarA, SoxS or Rob regulate the PompF promoter 
directly (Pomposiello et al., 2001, Barbosa and Levy, 2000). However, whether 
MarA and Rob may work as accessory regulators to OmpR at the PompF promoter 
remains a possibility. 
 
OmpF reduction during salicylate exposure is mediated through a MicF-
dendent and a MicF-independent pathway. A notable result from Figures  5.2  
and 5.3 is that levels of OmpF translation and expression in a marRAB soxRS 
rob triple mutant do not match those observed in a micF null mutant. These data 
suggest the possibility of an additional mar/sox/rob-dependent pathway for 
reducing OmpF translation.  
To further explore this possibility, we constructed mutants lacking marRAB 
and rob in an otherwise micF background. In this way, we can then determine 
which of the key regulators MarA and/or Rob is responsible for regulating the 
MicF-independent pathway. From the data present in Figure 5.4, we observe in 
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a micF mutant that only MarA-dependent factors contribute to further reduction of 
OmpF expression. Based on these results, we propose the existence of a MicF-
independent, post-translational mechanism for the reduction in OmpF expression 
during salicylate exposure. As these data strongly demonstrate that the effects 
are mediated at the level of ompF mRNA translation, we further propose that the 
regulatory element involved may be an additional sRNA regulator of ompF 
mRNA translation or stability. Specifically, this mechanism is under the 
transcriptional regulation of MarA (Figure 5.4E). 
 
Upregulation of PompC promoter activity is independent of Rob. Our results 
(Figure 5.1 and Figure 5.5) indicate that PompC transcription is upregulated in the 
presence of salicylate. These data concur with observations made in previous 
studies (Rosner et al., 1991). To gather whether MarA and Rob contributed to 
this increase in activation, we introduced marRAB and rob deletions into a strain 
harboring a single-copy transcriptional fusion of cfp to the PompC promoter after 
the ompC coding region (Batchelor et al., 2005). On exposure to salicylate, we 
observed that expression from the PompC promoter increases nearly two-fold, 
consistent with previous findings (Rosner et al., 1991). With regards to MarA and 
Rob being an effector of PompC activity, we observed no significant changes in 
PompC transcription in a marRAB, rob, or marRAB rob mutant. Collectively, these 
results demonstrate that PompC regulation during salicylate exposure is 
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independent of MarA and Rob despite the existence of mar/sox/rob regulatory 
sites in the close, divergently oriented PmicF promoter. 
 
Rob is a suppressor of OmpF reduction in tolC mutants. Decreased levels of 
OmpF expression in tolC mutants was a phenotype discovered by Misra and 
Reeves to be suppressed by deletions in the micF coding region (Misra and 
Reeves, 1987). However, these results were unable to ascribe the source of 
PmicF upregulation that resulted in reduced levels of OmpF. Recent data from 
Rosner and Martin suggest that the source of increased PmicF activity in tolC 
mutants is the result of upregulation of marRAB, soxRS, and rob (Rosner and 
Martin, 2009). Based on these findings, we wished to determine which of the 
mar/sox/rob systems contribute to the OmpF- phenotype observed in a tolC 
mutant. Specifically, we studied the effects of MarA, SoxS, Rob, and MicF on the 
expression of transcriptional and translational fusions described previously.  
 In the absence of tolC we observed that levels of PmicF promoter activity 
were increased and ompF translation was decreased, consistent with previous 
findings. The result of introducing marRAB, soxRS, and rob deletions into the 
tolC mutant background indicated that Rob is the primary mediator of PmicF 
activation, and thereby inhibition of ompF mRNA translation through MicF 
expression (Figure 5.6B and 5.6C). Examining the OmpF content in the outer 
membrane of these mutants also supports the previous findings (Figure 5.7).  
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Though Rob activation is shown to be the source of increased MicF 
expression, and ultimately decreased OmpF expression, these findings do not 
directly indicate the source of Rob activation. Whether this is caused by 
increased intracellular metabolites or perturbation of other elements of cellular 
physiology remains to be seen. Collectively, these data indicate that Rob is the 
primary regulator involved in increased MicF expression in tolC mutants. The role 
of MarA and SoxS in this instance appears to be minor. 
  
5.3 Discussion 
In this chapter, we have answered two outstanding questions regarding the 
regulatory role of the mar/sox/rob network in modulating the expression of outer 
membrane porins OmpF and OmpC. Specifically, we have demonstrated that 
MarA and Rob function as parallel regulatory pathways to down-regulate OmpF 
expression during growth in salicylate. Previous reports have shown that the 
absence of marA alone was insufficient to suppress the OmpF- phenotype 
produced by salicylate exposure (Cohen et al., 1993b). This was an unexpected 
finding as constitutive expression of MarA resulted in a similar phenotype to 
salicylate induced cells (Cohen et al., 1988). Based on our results, we suggest a 
model where activation of PmarRAB and Rob exist as two functionally redundant 
pathways for PmicF promoter activation, MicF expression, and reduced OmpF 
expression during exposure to salicylate.  A consequence of this model is that on 
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loss of either marRAB or rob, only a partial decrease in PmicF promoter activity is 
observed, while the overall expression of OmpF remains low enough to produce 
an OmpF- phenotype. This provides a near complete explanation for the 
observations of Cohen and coworkers (Cohen et al., 1993b, Cohen et al., 1988). 
 As a corollary to examining the role of MarA and Rob in reducting OmpF 
expression, we provide strong evidence for the existence of a MarA-dependent, 
MicF-independent pathway for reduction of ompF translation. Based on these 
findings, we also speculate that this may be the result of an unknown sRNA 
under the regulation of MarA. Traditional microarray analysis employed to study 
the mar/sox/rob regulon would not have detected increased transcription of 
unknown RNA reading frames. As a result, pinpointing possible sRNA candidates 
remains a future challenge. 
On one hand, this result was not surprising as the expression of MarA and 
activation of Rob both occur on salicylate exposure. Given the current regulatory 
model (Chapters 3 and 4), however, this result is of particular interest. Primarily, 
this observation uncovers a case where the existence of the Rob-MarA 
feedfoward loop is not relevant for phenotypic regulation. In other words, it would 
appear that the structure of mar/sox/rob feedfoward network may not only be 
influenced by the regulatory connections amongst MarA, SoxS, and Rob but also 
by the affinity of these regulators for certain downstream targets. We draw further 
support for this hypothesis from the observation that MarA, SoxS and Rob are 
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known to have differential affinity for downstream target promoters (Martin et al., 
2000, Martin et al., 2008). Taking this into account with our current observations 
provides further evidence to the complexity of the mar/sox/rob regulatory network 
and its regulation. 
We have also provided a clear regulatory explanation for the observation 
of Misra and Reeves regarding OmpF reduction in tolC mutants (Misra and 
Reeves, 1987, Morona and Reeves, 1982). Initially, suppressors of the tolC-
mutant OmpF phenotype were mapped to deletions in micF. Likewise, it was 
found that an increase in PmicF promoter activity was present in tolC mutants 
(Misra and Reeves, 1987). Recently, Rosner and Martin have shed light on 
aspects of this problem by discovering that the mar/sox/rob regulon is partially 
activated in the absence of tolC (Rosner and Martin, 2009). Following this line of 
evidence, we have show that the primary source of PmicF promoter upregulation 
under these conditions is Rob. The exact source of Rob activation in tolC 
mutants remains unknown and the source of future investigation. 
An additional point of interest is regarding the role of MarA and Rob in 
altering the levels of PompF promoter activation. Under salicylate exposure and in 
tolC mutants we observed that a marRAB rob double mutant resulted in nearly 2 
fold reductions in PompF promoter activity. Similarly, we observed the same 
decreases in activity for micF mutants. As MarA and Rob both regulate the PmicF 
promoter, and in their absence PmicF promoter activity is reduced to near 
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undetectable levels, we suspect that this is due to the loss of micF and not MarA 
and Rob directly. A full explanation for this cannot be provided by our results. 
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5.4 Figures 
 
 
 
 
 
Figure 5.1. The levels of OmpF and OmpC in the outer membrane of MG1655 
and a ΔompR mutant (LC915). Cells were grown overnight in of Medium A and 
subculture 1:200 in 10 ml fresh Medium A in absence or presence of 5 mM 
salicylate. Insoluble membrane fractions were prepared as described in Materials 
and Methods and displayed on 10% polyacrylamide gel with 6M Urea and SDS. 
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Figure 5.2. Expression from transcriptional and translational fusions in mutants 
with marRAB, soxRS, and rob systematically deleted. A.) Transcriptional fusion 
to the PompF promoter (LC1106, LC1207, LC1208, LC1209, LC1210, LC1211, 
LC1212, LC1097, LC1213). B.) Translational fusion to the first 13 amino acids of 
OmpF (LC1108, LC1200, LC1201, LC1202, LC1203, LC1204, LC1205, LC1099, 
LC1206). C.) Transcriptional fusion to the PmicF promoter (LC439, LC693, LC694, 
LC695, LC696, LC697, LC698, LC699, LC1214). Cells were grown overnight in 
Medium A and subculture 1:200 in Medium A containing 5 mM salicylate. 
Cultures were grown in 550 µl aliquots in 2.2 ml, deep well plates with shaking at 
1000 rpm for 4 hours. Fluorescence and optical density measurements were 
made on 250 µl aliquots of culture in a Tecan Safire2 microplate reader. 
  
116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. The levels of OmpF and OmpC in the outer membrane with 
systematic deletions in the mar/sox/rob regulatory network and micF (MG1655, 
LC496, LC321, LC320, LC497, LC701, LC322, LC539, LC1109). Cells were 
grown overnight in of Medium A and subculture 1:200 in 10 ml fresh Medium A in 
the presence of 5 mM salicylate. Insoluble membrane fractions were prepared as 
described in Materials and Methods and displayed on 10% polyacrylamide gel 
with 6M Urea/1%SDS. 
  
117 
 
 
 
 
 
 
Figure 5.4. A MicF-independent pathway for OmpF reduction is regulated by 
MarA during salicylate exposure. . A.) Transcriptional fusion to the PompF 
promoter (LC1106, LC1213, LC1225, LC1226, LC1227). B.) Translational fusion 
to the first 13 amino acids of OmpF (LC110, LC1206, LC1228, LC1229, LC1230). 
C.) Transcriptional fusion to the PmicF promoter (LC439, LC1214, LC1231, 
LC1232, LC1233). D.) Insoluble membrane fractions of mutants grown in 5 mM 
saliclyate. Cells were grown overnight in of Medium A and subculture 1:200 in 10 
ml fresh Medium A containing 5 mM salicylate. Insoluble membrane fractions 
were prepared as described in Materials and Methods and displayed on 10% 
polyacrylamide gel with 6M Urea and 1% SDS. E.) A model of the MicF-
dependent pathway and its possible regulation. 
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Figure 5.5. MarA and Rob have no apparent affect on ompC transcription. Cells 
were grown overnight in Medium A and subculture 1:200 in Medium A with or 
without 5 mM salicylate. Cultures were grown in 550 µl aliquots in 2.2 ml, deep 
well plates with shaking at 1000 rpm for 4 hours. Fluorescence and optical 
density measurements were made on 250 µl aliquots of culture in a Tecan 
Safire2 microplate reader. 
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Figure 5.6. Expression from transcriptional and translational fusions in tolC 
mutants lacking marRAB, soxRS, rob, and micF. A.) Transcriptional fusion to the 
PompF promoter (LC1106, LC1184, LC1185, LC1186, LC1187, LC1188, LC1189). 
B.) Translational fusion to the first 13 amino acids of OmpF (LC1108, LC1178, 
LC1179, LC1180, LC1181, LC1182, LC1183). C.) Transcriptional fusion to the 
PmicF promoter (LC439, LC623,  LC1190, LC1191, LC1192, LC1193, LC1194). 
Cells were grown overnight in Medium A and subculture 1:200 in Medium A 
containing 5 mM salicylate. Cultures were grown in 550 µl aliquots in 2.2 ml, 
deep well plates with shaking at 1000 rpm for 4 hours. Fluorescence and optical 
density measurements were made on 250 µl aliquots of culture in a Tecan 
Safire2 microplate reader. 
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Figure 5.7. The levels of OmpF and OmpC in the outer membrane with deletions 
in the mar/sox/rob regulatory network and micF in the absence of tolC (MG1655, 
LC614, LC1165, LC1166, LC1167, LC1164, LC1117). Cells were grown 
overnight in of Medium A and subculture 1:200 in 10 ml fresh Medium A. 
Insoluble membrane fractions were prepared as described in Materials and 
Methods and displayed on 10% polyacrylamide gel with 6M Urea and SDS 
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Chapter 6: Aromatic acid metabolites of Escherichia coli K-12 
can induce the marRAB operon 
 
6.1 Introduction 
The majority of this chapter has been published in the Journal of Bacteriology 
(Chubiz and Rao, 2010). A central regulator of intrinsic antibiotic resistance and 
organic acid tolerance in Escherichia coli and related enteric bacteria is MarR, a 
negative autoregulator of the marRAB operon (Ariza et al., 1994, Cohen et al., 
1993a, Cohen et al., 1993c, Maneewannakul and Levy, 1996, Martin et al., 1995, 
Martin and Rosner, 1995, Alekshun and Levy, 1997, Chollet et al., 2002). This 
protein is a canonical member of a family of transcriptional repressors commonly 
associated with regulating the expression of multi-drug efflux systems, stress-
response systems, metabolic pathways and virulence factors ((Wilkinson and 
Grove, 2006) and references therein). A common theme amongst MarR-family 
regulators is the ability to bind structurally disparate anionic lipophilic 
compounds. In the case of MarR, numerous chemical compounds such as 
benzoate, salicylate, 2,4-dinitrophenol, menadione, and plumbagin have been 
shown to modulate its activity both in vivo and in vitro (Alekshun and Levy, 
1999a, Alekshun et al., 2001, Martin and Rosner, 1995, Seoane and Levy, 1995, 
Cohen et al., 1993b). Additionally, MarR activity is affected through protein-
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protein interactions with enzymes such as transketolase A and DNA gyrase 
subunit A (Domain et al., 2007, Domain and Levy, 2010). 
Recently, Rosner and Martin found that in an E. coli tolC mutant the marRAB 
promoter was upregulated approximately two-fold (Rosner and Martin, 2009). 
They concluded from these results, that upon loss of TolC-dependent excretory 
capacity, cells accumulate metabolic intermediates capable of inducing the mar 
system. Intrigued by this hypothesis, we examined a number of metabolic 
pathways and hypothesized that those involved in the superpathway of 
chorismate may be potential effectors of MarR given their chemical similarity to 
its known ligands. In this work, we show that three such intermediates in 
aromatic amino acid biosynthesis activate marRAB transcription in vivo when 
supplied endogenously and that one, 2,3-dihydroxybenzoate, directly binds to 
MarR in vitro.   
 
6.2 Results 
Aromatic metabolic intermediates activate the marRAB operon in vivo. Of 
the several known inducers of marRAB expression, the best characterized is 
salicylate, a weak aromatic acid (Cohen et al., 1993b, Seoane and Levy, 1995, 
Alekshun and Levy, 1999a, Alekshun et al., 2001, Martin and Rosner, 1995). 
Specifically, salicylate has been shown to directly bind MarR (Martin and Rosner, 
1995, Alekshun et al., 2001). If metabolic intermediates are potential ligands for 
MarR, we surmised that that they may have similar chemical structure to the 
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canonical inducer salicylate. Among the vast number of metabolic intermediates 
in E. coli metabolism, those involved in the superpathway of chorismate 
appeared to be the most promising (Keseler et al., 2009).  
Examination of this superpathway in E. coli K-12 yielded four compounds 
that were structurally similar to salicylate (Figure 6.1A). Our basis for assessing 
similarity was the presence of a carboxylate group with adjacent hydroxyl or 
amine groups on the benzyl ring. Four putative compounds were identified: 4-
hydroxybenzoate (HBA), an intermediate in ubiquinone-8 biosynthesis; 2,3-
dihydroxybenzoate (DHB), an intermediate in enterobactin biosynthesis; 
anthranilate (ANT), an intermediate in tryprophan biosynthesis; and 4-
aminobenzoate (PABA), an intermediate in tetrahydrofolate biosynthesis.  
To test whether these compounds were inducers of the marRAB operon, 
we used a chromosomal, single-copy transcriptional fusion of the marRAB 
promoter to the fast-folding YFP variant Venus to monitor gene expression in the 
presence of the four potential inducers (Nagai et al., 2002). For comparison, we 
also explored the ability of these chemicals to activate expression in a tolC null 
mutant. Of the four, we found that only DHB and ANT activate the marRAB 
promoters in wild-type cells (Figure 6.1B). We also found that HBA could 
activate the marRAB promoter in a tolC null mutant. Interestingly, PABA failed to 
activate the marRAB promoter despite its chemical similarity to salicylate.  
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MarR binds 2,3-dihydroxybenzoate. We next tested whether MarR directly 
binds to DHB, ANT, and HBA. To measure binding, we employed isothermal 
titration calorimetry (ITC) using purified MarR (Figure 6.2). Consistent with 
previous measurements, we found that the affinity of MarR for salicylate was 
Kd=0.9 mM, well within the ranges reported using other methods (Martin and 
Rosner, 1995, Alekshun and Levy, 1999a). Binding was not observed with 
isopropyl β-D-1-thiogalactopyranoside (IPTG), which served as our negative 
control. We also found that MarR bound DHB with a Kd=0.5 mM. However, we 
found that ANT did not bind to MarR even though it was capable of activating the 
marRAB promoter. Similarly, we found that HBA, which activates the marRAB 
promoter only in the absence of tolC, also did not bind to MarR (data not shown). 
This suggests that these two compounds may indirectly regulate marRAB 
promoter activity. 
We note that despite MarR having similar affinities for the two, salicylate 
has a greater effect than DHB on marRAB activation in vivo. To explain these 
results, we imagine that DHB is likely being metabolized by the cell. Consistent 
with this hypothesis, we observed increased levels of DHB-dependent marRAB 
promoter activation in a tolC mutant background (Figure 6.1B), suggesting loss 
of the excretory function of TolC may lead to a buildup of DHB, most likely by 
preventing the efflux of the downstream metabolite, enterobactin (Bleuel et al., 
2005). 
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MarR activity is modulated in vitro by 2,3-dihydroxybenzoate. As MarR binds 
to DHB, we next tested whether it affects MarR binding to the marRAB promoter 
region. To determine loss of MarR binding activity in the presence of DHB, we 
employed electrophoretic mobility shift assays using purified MarR and a 150 
base-pair region of marRAB promoter (see Supplement for details). Using 
salicylate as our positive control and IPTG as our negative control, we found that 
only DHB directly affected MarR activity (Figure 6.3). Interestingly, we observed 
significantly more unbound DNA in the presence of DHB than salicylate, even 
though MarR has similar binding affinities for the two. We also tested whether 
ANT affected MarR activity and found that it did not, consistent with our ITC 
experiments.  
 
Disruptions in enterobactin and tryptophan biosynthesis affect marRAB 
promoter activity in tolC mutants. Our previous results have demonstrated that 
DHB and ANT activate the marRAB promoter in vivo when added exogenously. 
To better correlate the metabolite effector hypothesis of Rosner and Martin to 
these observations, we disrupted enzymatic steps in enterobactin and tryptophan 
metabolism that block either the synthesis or utilization of DHB or ANT. 
Specifically, mutants lacking the enterobactin synthesis pathway (ΔentCEBAH) 
or deficient in 2,3-dihydro-2,3-dihydroxybenzoate (DDHB) dehydrogenase (entA), 
enterobactin synthase (entF), anthranilate synthase (trpE), and phoshoribosyl 
transferase (the C-terminal region of trpD) activities were constructed in 
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otherwise wild type and tolC mutant strains and tested for alterations in marRAB 
promoter activity. 
In TolC+ backgrounds, we observed no significant changes in marRAB 
promoter activity in any of the mutants, presumably due to the ability of these 
cells to readily excrete accumulated intermediates (data not shown). However, 
when we repeated these experiments in the absence of TolC, we found that 
marRAB promoter was less active in mutants unable to synthesize enterobactin 
from chorismate (ΔtolC: 1559±170 vs. ΔtolC ΔentCEBAH: 1387±195 RFU/OD, 
P=0.001). However, when we attempted to accumulate the DHB in the cell by 
blocking conversion of DHB to enterobactin, we observed a decrease in marRAB 
promoter activity as opposed to an expected increase (ΔtolC: 1559±170 RFU/OD 
vs. ΔtolC ΔentF: 1491±78 RFU/OD, P=0.04). While statistically significant, the 
effect is minor and likely not physiologically significant. We suspect that this 
mutant (ΔtolC ΔentF) does not accumulate significant amounts of DHB. 
Interestingly, we observed a significant increase in marRAB promoter activity 
when we blocked the conversion of DDHB to DHB (ΔtolC: 1559±170 vs. ΔtolC 
ΔentA: 1737±133 RFU/OD, P=0.0001). Given the similar chemical structures of 
DDHB and DHB, differing only by a hydrated 2,3 carbon-carbon bond on the 
benzyl ring, we suspect that DDHB may accumulate in this mutant and serve as 
an alternate activator of MarR. Collectively, these results suggest that 
enterobactin intermediates are physiological activators of the marRAB operon. 
127 
 
We also investigated the effects of tryptophan biosynthesis on marRAB 
expression in the absence of TolC. We found that mutants unable to convert ANT 
to tryptophan did not exhibit any significant changes in marRAB promoter activity 
(data not shown). Interestingly, in the absence of anthranilate synthase, and 
therefore the ability to synthesize ANT, we observed a statistically significant 
increase in the marRAB promoter activity (ΔtolC: 1516±68 vs. ΔtolC ΔtrpE: 
1702±173 RFU/OD, P<0.00002). We suspect that blocking the initial step of 
tryptophan biosynthesis may redirect metabolic fluxes to other pathways where 
the metabolitic intermediates induce marRAB expression. Taken together, these 
results indicate that disrupting tryptophan biosynthesis affects marRAB 
expression, though they suggest that tryptophan intermediates do not contribute 
directly to the tolC phenotype. Moreover, the effect is not direct nor is the 
mechanism clear. We were not entirely surprised by this result as we found that 
ANT does not directly bind MarR and affect its activity. Rather, the effect appears 
to be indirect. 
 
6.3 Discussion 
A number of studies have shown that some metabolic intermediates are inducers 
and substrates for various efflux pumps (Carole et al., 1999, Van Dyk et al., 
2004, Helling et al., 2002, Liu et al., 1999a, Liu et al., 1999b). Likely, these 
mechanisms prevent the buildup of toxic metabolic intermediates. In support of 
this model, our results demonstrate that MarR directly binds one such 
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intermediate, 2,3-dihydroxybenzoate, involved in biosynthesis of enterobactin, 
itself a substrate for TolC (Bleuel et al., 2005). Whether DHB is a MarR effector 
under physiological conditions, however, is still unknown. 
While these results suggest that enterobactin biosynthesis contributes to 
the increase in marRAB expression in the absence of TolC, they do not explain 
the phenotype completely. Due to the magnitude of the changes in marRAB 
expression caused by mutations in the enterobactin pathway, we suspect that the 
true source of increased activation is likely a combination of many intracellular 
metabolites as proposed by Rosner and Martin (Rosner and Martin, 2009). 
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6.4 Figures 
 
 
Figure 6.1. Activation of the marRAB operon by aromatic acid metabolites in the 
superpathway of chorismate. (A) Chemical structure of metabolites selected 
based on their similarity to salicylate. (B) Observed transcriptional activation of 
the marR’-yfp promoter fusion in the presence of 5 mM concentrations of 
indicated inducers in wild-type (LC433) and ΔtolC mutant (LC621) backgrounds. 
Salicylate (SAL) and IPTG served as positive and negative controls for activation, 
respectively. Cells were grown overnight in MOPS minimal media (20 mM 
glucose, 0.2% casamino acids, pH = 7.2) and subcultured 1:200 in fresh media. 
Following dilution, 450 µl of culture was transferred to deep 96-well plates and 
grown at 37oC with aeration at 1000 rpm to an OD=0.5. At this time, 100 µl of 
media containing dissolved inducer was added. Growth was continued for an 
additional 2 hours prior to fluorescence and optical density measurements made 
with a Tecan Safire2 microplate reader. 
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Figure 6.2. MarR binding of aromatic acid inducers as determined by isothermal 
titration calorimetry (ITC). Experiments were conducted using a VP-ITC 
calorimeter (MicroCal) with 1.4 mL MarR at 10 µM and ligands at a concentration 
of 10 mM, both in tris-buffered saline (50 mM Tris, 150 mM NaCl, pH = 7.4). In 
the case of ANT and HBA, higher concentrations of ligand were also tested 
though again no binding was observed. Titration reactions were performed with 
28 injections, all 10 µl in volume, with constant stirring at 300 rpm at 25oC. Data 
acquisition and binding coefficients were determined with the Origin-based 
MicroCal analysis software. 
  
131 
 
 
 
 
Figure 6.3. MarR DNA binding activity in the presence of aromatic acid 
metabolites as determined by electromobility shift assays. Binding reactions 
consisted of 20 ng of purified MarR and 5 ng of a radiolabeled, 150 bp fragment 
of the marRAB promoter containing two MarR operator sites. Ligands salicylate 
(SAL), 2,3-dihydroxybenzoate (DHB), anthranilate (ANT) and IPTG were 
supplied at increasing concentrations of 2.5 mM, 5 mM, and 10 mM to binding 
reactions. Reactions were displayed on 5% acrylamide, 0.5X TBE buffered gels. 
Loss of MarR DNA binding activity was monitored by the emergence of free DNA 
in the presence of these ligands. Salicylate and IPTG served as positive and 
negative controls respectively. 
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Chapter 7: Conclusions and Future Directions 
 
7.1 General conclusions 
In this work, an integrated, testable regulatory model for the mar/sox/rob network 
has been established. In the process of defining an integrated model we also 
confirmed that the global regulator CRP binds to the PmarR promoter directly. An 
important consequence of this finding is that it appears information regarding the 
nutritional state of the cell is fed into the marRAB circuit; in addition to numerous 
exogenous chemical signals that are known to influence expression of the 
mar/sox/rob regulon. We also were able to use the model to test predictions 
about the behavior of a feedforward regulatory loop formed by Rob and MarA. 
The outcome of this examination was the discovery that MarA acts as a 
conditional, negative autoregulator in the presence of Rob. We propose that this 
mechanism serves to establish set-point control on marA gene expression. 
 Using the interconnected model as a basis we were also able to explore 
the role of the mar/sox/rob regulatory circuits in altering outer membrane porin 
compositions. Specifically, we were able to demonstrate that it is through the 
combined action of Rob and marRAB that OmpF expression is reduced in the 
presence of salicylate. Additionally, we were able to show that the OmpF- 
phenotype observed in tolC mutants is the result of Rob activation alone. These 
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results highlight the overlapping nature of the mar/sox/rob regulon and that to 
produce similar output phenotypes under different conditions requires a fully 
intact regulatory network. 
 Finally, we were able to demonstrate that intermediary metabolites in the 
superpathway of chorismate are capable of activating the marRAB genetic 
system. In particular, the enterobactin intermediate, 2,3-dihydroxybenzoate, is 
capable of binding to MarR directly, affecting DNA binding activity. Further, we 
provided genetic evidence that disruptions in enterobactin biosynthesis can 
contribute, in part, to the upregulated PmarR activity observed in tolC mutants. 
Collectively, these results point to the necessity of examining intermediary 
metabolites as inducers of intrinsic multiple antibiotic resistance. Further, these 
results supply evidence for arguments that multidrug efflux systems may have 
evolved to combat the accumulation of metabolites and not necessarily 
antibiotics. 
 
7.2 Future directions 
Metabolite inducers of Rob. The results of Chapter 5 clearly show that Rob is 
the primary mediator of OmpF downregulation in tolC mutants. However, these 
results do not point to the true cause of Rob activation. As we have shown 
metabolites are capable of inducing the marRAB system in Chapter 6, it is easy 
to imagine that metabolites may also be activators of Rob. To test this 
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hypothesis, we propose that transposon mutagenesis and screening be done in a 
tolC genetic background where all three regulatory systems are removed (strain 
LC539) and harbors a fusion of lacZ to PmicF. Additionally, Rob is expressed 
ectopically by a constitutive promoter. Based on our observations, in mutants 
lacking marRAB, soxRS, and rob the PmicF promoter is severely downregulated in 
all medias explored. In these mutagenesis experiments, one would look for 
mutants with a downregulated PmicF phenotype (in this case LacZ
-). Ectopic 
expression of Rob will control for Prob dependent expression effects as well as 
reduce the false positive rate produced by insertions made in the rob coding 
region. Considering our data, this screen appears entirely possible and will likely 
yield a number of possible new avenues for further exploration. 
  
A high-throughput screen for MarR substrates. We have demonstrated in 
Chapter 6 that sufficient quantities of MarR can be purified under native 
conditions to perform biochemical analysis and binding assays such as 
isothermal titration calorimetry (ITC). Utilizing high-throughput methods such as 
the recently developed photonic crystal biosensor assay for DNA binding proteins 
would allow large chemical libraries to be screened against MarR to find 
additional activators. As the substrate specificity of MarR appears to be broad, 
yet somewhat specific (see Chapter 6), identifying larger families of chemical 
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structures that MarR will bind may allow for the “true” inducers of MarR to be 
systematically identified. 
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